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ABSTRACT 
The goal of this dissertation research was to develop, implement, and test an 
automated decision system to provide early detection of actual acute 
bronchopulmonary events in a population of lung transplant recipients following a 
home monitoring protocol.   
Decision rules were developed using wavelet analysis of spirometry and symptom 
signal data collected daily at home by the lung transplant recipients, and 
transmitted weekly to our study data center.  Rules were developed based on a 
learning set of patient home data, and validated with an independent set of 
patients.  
Using either FEV1 or symptom-based home data monitoring, the detection 
algorithm can capture the majority of events (sensitivity > 80%) at an acceptable 
level of false alarms. Detection occurs 6.6 to 10.8 days earlier than the 
corresponding events recorded in the patient’s clinical records. Combining rules 
using the Dempster-Shafer theory of evidence incrementally improves 
performance over a single variable.  
This framework can be readily implemented as an automatic event detection tool 
to aid medical discovery and diagnosis of acute pulmonary events. 
 
Keywords: 
Lung transplant, home monitoring, spirometry, pulmonary function testing, 
event detection, wavelets, CUSUM, operating characteristics, Dempster-Shafer, 
classifier combination 
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KEY ABBRIEVATIONS 
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LTx        Lung transplant 
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PFT     Pulmonary function test 
FEV1  Forced expiratory volume in 1 second; volume of air forcibly expired from   
a maximum inspiratory effort in the first second (L) 
FVC      Forced vital capacity; the total volume that can be forcefully expired from a   
maximum inspiratory effort (L) 
FFr       FEV1 to FVC ratio     
FEF      Forced expiratory flow.  
PEFR/PFR    Peak expiratory flow rate; the highest forced expiratory flow (L/second) 
MEFR/ FEF25-75/MFR   Mid expiratory flow; the forced expiratory mid flow rate at 
25 to 75 percent of forced vital capacity (L/second) 
SNR     Signal to noise ratio 
MA        Moving average 
WMSA  Wavelet-based multiscale analysis 
DWT     Discrete wavelet transform 
OC        Operating Characteristics 
CUSUM Cumulative sum 
DST      Dempster-Shafer (DS) theory of evidence 
PDF      Probability distribution function 
bpa        Basic probability assignment  
BOE      Body of evidence  
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C h a p t e r  I   
INTRODUCTION AND OVERVIEW 
Introduction 
Lung transplant recipients are at high risk of post surgery complications such 
as infection and rejection, two leading contributors to morbidity and mortality [1]. 
Patient survival remains inferior to other organ transplantations such as heart and 
liver [ 2 , 3 , 4 , 5 ], primarily due to severe consequence of allograft-related 
complications. Many transplant centers recommend that lung recipients perform 
daily monitoring at home, which may detect early signs of transplant complications 
and thus enable timely diagnosis and treatments [6,7,8]. Survival of lung transplant 
recipients is enhanced when infection or rejection is detected early and appropriate 
therapies are implemented [9,10]. Early intervention may also reduce cost and 
improve quality of life [ 11 ]. Therefore, early detection of lung transplant 
complication events is of paramount importance to these patients.  
Studies have shown that it is feasible to detect general clinical problems early 
by monitoring pulmonary functions (spirometry) and symptoms from patient’s 
home [12, 13]. Spirometry quantifies pulmonary function changes by measuring 
the amount and speed of air that can be inhaled and exhaled with maximal effort in 
limited time, therefore, provides mechanistic insight into the physiologic impairment 
of the lungs. Spirometry is known for recognizing pulmonary pathology [14] and is 
routinely used to aid diagnosis of lung disease [15]. Reliable and valid spirometry 
measurements can be obtained by patients in a home setting and are comparable 
to the measurements obtained in clinic [16]. Home based testing with a portable 
spirometer permits higher testing frequency as compared to in-clinic visits, 
therefore, enables early detection of clinical problems. In particular, in the lung 
transplant home monitoring program at the University of Minnesota (LTHMP), 
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Finkelstein and colleagues demonstrated that home spirometry could detect 
Bronchiolitis Obliterans Syndrome staging, a syndrome considered to be related to 
chronic rejection [12] at its early stage. An automated triage decision support 
system can identify which participants have demonstrated critical level of concerns 
to be on a closely “watched” list [17]. At other institutions, Wagner and colleagues 
reported telemetric monitoring for reliable early diagnosis and treatment of 
infection and rejection [14]. Morlion and colleagues reported an internet-based 
home monitoring approach to detect acute events [18]. The possibility of early 
detection of related pathologies through home monitoring has thus been fairly well 
documented for the bronchopulmonary conditions. 
Challenges and Motivations 
Recent technological advancements have made home monitoring more 
convenient and more reliable. However, new challenges emerge as more data 
need timely processing and relevant decisions. From the clinician’s perspective, 
one key objective that remains unresolved is how to utilize the home data to detect 
clinical events in a prompt and reliable manner.   
The long term home monitoring for the lung transplant recipients in a clinical 
setting presents numerous challenges: Data are extremely precious and there are 
no public data available. There is paucity in public research over the last decade 
per a Medline/PubMed database search using the key words of “spirometry 
monitoring”. To this end, this research studied proprietary data from two cohorts of 
consented lung transplant recipients in LTHMP, and investigated methods 
customized for this type of data. 
As to be illustrated, the home spirometry data series are nonlinear 
nonstationary with wide range of inter- and intra- subject variability, which can be 
difficult for clinicians to interpret. It is unknown if the data fluctuation encodes 
pertinent event information, and if it does, how an event will exhibit itself in data 
and how best to decode it. The underlying disease development and progression 
can be masked among other factors such as inconsistency in patient’s physical 
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effort. The data variation due to an event needs to be separated from the 
background noise.  The problem can multiply as the types of events and patients’ 
reaction to events vary.  Therefore, simple guidelines and heuristics do not readily 
meet the challenges of the complexity in data for accurate signal estimation and 
subsequent event detection.  
Another challenge involves how to retrieve relevant information from the 
different data types and reach reliable decisions quicker. This problem is two-fold:  
On one hand, clinicians have busy schedules. Modern home monitoring 
technology often provides great amount of data, which would not be useful if they 
can not be timely digested and utilized. In LTHMP, patients were instructed to 
perform daily spirometry and record symptoms along with vital information. A 
home monitoring report may consist of up to ten spirometric, five symptom, five 
health status/ well-being, and five vital sign variables. These multidimensional data 
accumulate over time and increase the burden to data review. One must 
determine which monitoring variables are most essential.  
On the other hand, event detection based on a single variable input can be 
suboptimal. For example, Morlion’s study reported a sensitivity of 63% in detecting 
acute rejection based on spirometry monitoring and questioned the potentially 
missed detection by spirometry alone [18]. Therefore, there is a desire to combine 
different classes of monitoring data for better detection. To date, there is paucity in 
this domain literature in regard to how to meaningfully combine such information. 
This prompts investigating techniques to boost detection performance. However, 
distinctive types of variables are interpreted very differently. Each data type 
requires customized processing. This is because spirometry and symptoms 
acquire their evidence based on totally different criteria: spirometry is effort-based 
and equipment measured, and symptoms are self assessed. Generally, such 
distinctive data types can not be combined due to different characteristics and 
embedded noise. Therefore, it is a technical challenge to combine the spirometry 
and symptom information.  
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Significance  
The critical nature of event detection suggests that effective and robust means 
be deployed to make use of suitable monitoring information.  
The significance of the research resides in the following: 
Contribution to lung transplant home monitoring. This research explores new 
signal analysis methods to detect events. Signal analysis is the least invasive 
approach, is compatible with the existing home monitoring infrastructure, and can 
be readily put into use. A systematic data screening approach could have a 
profound impact to the post-lung transplant surveillance and care. The resulting 
methods would provide automatic just-in-time detections. By establishing a well 
understood detection mechanism with clinically meaningful performance, this 
research would demonstrate further evidence of clinical utility, and might increase 
the acceptance of home monitoring of lung transplant patients. 
Patient welfare. Effective non-invasive computerized event detection should be 
pertinent and cost-effective for the detection of major transplant problems. Acting 
upon timely diagnosis, cost effectiveness, patients' quality of life and survival are 
expected to improve.  
Research enrichment. "Quantifying and modeling the complexity of health 
variability, and detecting more subtle alterations with disease and aging, present 
major challenges in contemporary biomedicine" [19]. Although the focus is on one 
discipline (lung transplant home monitoring), this work has general implication to 
the research of the long term care of the chronically ill. 
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Objectives and Specific Aims 
Previously, a decision support nursing triage algorithm has been developed to 
detect potential bronchopulmonary problems [17] for the LTHMP. This research 
aims to step further and develop a method that automatically detects actual clinical 
events based on the same home monitored spirometry and symptom data. The 
events are the actual events captured in the patient’s medical records.  
The first objective is to understand and characterize the home monitoring data 
and to determine an effective analytical approach. Secondly, it was a design factor 
that the detection could be implemented in a non-invasive computerized 
framework which eventually will operate in real time. The framework shall work 
within the existing infrastructure of data collection and assimilation of LTHMP.  
Previous research approaches [6,12,14,17,18, 20 ] have been critically 
reviewed. As the home monitoring data are noisy, nonlinear and nonstationary, 
this research first proposed a wavelet-based method which is a natural tool for 
multiresolution time dependent analysis and is well known to handle nonlinear 
nonstationary data. Wavelet method is the analytical foundation for event detection 
in this study.   
Next, based on the output of individual classifiers, a multi-classifier combination 
was implemented to enhance detection over the univariate approach. This 
combination rule is based on the Dempster-Shafer theory of evidence (DST).  
The desired algorithms are data driven, individually customizable and operable  
in real time. These algorithms can be used as decision-support to detect clinical 
events and to aid medical discovery/diagnostics. The ultimate goal is to improve 
lung transplant patient survivability. This decision aid is complementary and not a 
replacement to the primary care [21]. 
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The specific aims are to: 
1) Demonstrate the utility of wavelet-based method for characterizing and 
analyzing home monitored data. 
2) Derive event detection features to be tested with actual events. 
3) Demonstrate clinically relevant performance metrics which include 
sensitivity, specificity/ false alarm rate and timing of detections.  
4) Validate the detection design with broader previously unseen patient set 
and demonstrate reproducible results. The results from this research may possibly 
serve as a benchmark for future research with similar aims. 
 
This research consists of a two-stage structure of event detection, outlined in 
Figure 1. The first stage involves individual event classifier development based on 
the wavelet analysis. The second stage involves a multiple classifier combination 
based on the Dempster-Shafer theory. Performance is evaluated in the same 
manner for each approach. 
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Figure 1. Topics of the dissertation research 
Note: Abbreviations are noted on page vii. 
 
LTx Home Monitoring  
Time Series 
Spirometry: 
FEV1, FEV1/FVC,  
PEFR, MEFR 
Symptom: 
Cough, Sputum, Dyspnea, Wheeze 
Wavelet-based Multiresolution 
Signal Crossover Analysis 
Symptom Conversion 
Signal Crossover Analysis 
Multi-classifier Combination Based 
on Dempster-Shafer Theory 
Performance Evaluation 
Learning Set/ Validation Set 
 8
Organization of the Dissertation 
Chapter I provided introduction and overview, challenges and motivations, 
objectives and specific aims, significance and scope of the research. The rest of 
the dissertation is organized as follows: 
Chapter II describes domain specific background information and a literature 
review in topic areas concerning this research. The literature review also provides 
rationale and background of the chosen approaches in this research.  
Chapter III describes the materials that were used in this research. In 
particular, these datasets were used in developing, learning and validating the 
methods. Data characteristics are illustrated and summarized. Pre-analysis data 
processing was performed. 
A two-staged approach to event detection was implemented: 
Chapter IV focuses on the wavelet approach to data analysis, processing and 
derivation of univariate classifier, with the theoretical background outlined first. 
Based on a wavelet-estimated signal crossover, a sequential cumulative sum 
(CUSUM) classifier is proposed for event detection. Event detection and 
classification are illustrated through cases. Performance metrics are defined. 
Performance is evaluated for the learning set and the validation set, respectively.  
Chapter V focuses on the Dempster-Shafer approach to multi-classifier 
combination. Parallel to the wavelet-based univariate classifier, methods are 
illustrated with cases, and overall performance is evaluated for the learning set and 
the validation set, respectively, followed by comparing to results in Chapter IV.  
Chapter VI discusses the clinical relevance, impacting factors, utilities and 
limitations of the research. 
Chapter VII summarizes the contribution to research, concludes, then suggests 
future work. 
Appendices consist of additional technical background, the supporting work, 
documentation of computer code, and related work not included in the main body 
of the dissertation.          
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C h a p t e r  I I   
BACKGROUND AND LITERATURE REVIEW 
Lung Transplant  
Lung transplantation has become an acceptable therapeutic option of many 
end stage lung diseases [2,22].  
Since the inauguration of the annual report of the Registry of the International 
Society for Heart and Lung Transplantation (ISHLT) in 1984, there is a steady 
increase in the cases reported over the years as more institutions and databases 
worldwide are linked each year to report the prevalence [23,24]. Approximately 
30,000 adult lung recipients and 3500 adult heart-lung recipients have been 
reported around the world through 2008 in the ISHLT 2009 annual report [4]. In the 
US, the prevalence of people living with a functioning lung transplant at end of the 
year was 2,099 in 1995, 3,400 in 1999, 4,853 in 2003 and 6,731 in 2007 [25, 26, 
27, Figure 2]; For instance, there were 1,085, 1,468 and 1770 lung transplants 
performed in 2003, 2007 and 2010, respectively   [28,29].  
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Figure 2. Prevalence of lung transplant in the US. 
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The need for lung transplantation is due to lung failure. The most common 
diseases that result in lung failure include chronic obstructive pulmonary disease, 
emphysema, cystic fibrosis, idiopathic pulmonary fibrosis, primary pulmonary 
hypertension, bronchiectasis, sarcoidosis. The three main types of lung transplant 
are single lung, double/bilateral lung and heart-lung transplant [30].  
Certain physiologic changes are expected after lung transplantation. In 
particular, two important host defenses to lung infections are impaired: cough 
reflex and mucociliary transport. Since patients don't necessarily have sensation of 
the new denervated organs [31] and may have no early pain symptoms of a 
blockage building up, monitoring cannot rely on symptoms alone, especially in the 
early stage of 4-6 weeks post transplant. Pulmonary function should rise and level 
off during the first 3 months post transplant. Any time after the first 3 months, a 
sustained decline of pulmonary function could represent a potential problem [10].  
The common adverse effects after a successful transplant are rejection (acute 
and chronic) and infections. After a transplant, it is necessary to take 
immunosuppressants or antirejection medications to suspend the body's immune 
system and protect the transplant. The medication reduces the risk of organ 
rejection, however, it also increases the risk of infections in the newly transplanted 
organ. In lung transplantation, the organ is not matched to the patient except by a 
blood type, thus the transplant tissue could be very different from the native tissue. 
This means that rejection is more common and is often more severe than in other 
organ transplants such as kidney transplantation. The chronic rejection is also 
denoted as bronchiolitis obliterans (BO), in which there are obstructive changes in 
the airways of the lungs. Other effects include high blood pressure, diabetes 
mellitus, high cholesterol, reappearance of lung disease, cancer, osteoporosis, 
cataract, and kidney disease. Nearly all patients will have at least one or more 
rejection episodes after transplant surgery [32].  
Infections are more likely since there is direct exposure to pathogens in the 
environment [33]. Community acquired respiratory viruses and bacteria, such as 
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Methicillin-resistant Staphylococcus aureus (MRSA), has also been recognized as 
a major cause of morbidity and mortality [ 34 ]. Graft failure and non-
cytomegalovirus (CMV) infections were the principal fatal complications in the first 
30 days, and bronchiolitis obliterans/ Bronchiolitis Obliterans Syndrome (BOS), a 
manifestation of chronic rejection, has been the single largest contributor to late 
mortality [2,23]. About 50% of lung recipients [23], and 30% to 50% percent heart-
lung recipients develop bronchiolitis obliterans post-transplant [32]. Once 
established, bronchiolitis obliterans is difficult to treat.  
Acute rejection occurs in 35% to 50% of lung transplant recipients and is an 
important risk factor for chronic rejection/ bronchiolitis obliterans. Acute rejection, 
by itself, is usually not life or graft threatening, and its abnormal histology can be 
reversed with treatment [35]. Thus, early diagnosis and treatment with augmented 
immunosuppression might help reduce the amount of irreversible parenchymal 
injury in the allograft [14] , and offer the best hope of decreasing the lethality of this 
complication [2,36 , 37 ]. Rejection is characterized by fever, dyspnea, cough, 
sputum production, rapidly developing pulmonary infiltrate, and pulmonary 
decompensation [36,38] such as decreased SaO2 (oxygen saturation test) and 
forced expiratory volume at one second  (FEV1). 
To carefully monitor transplant patients for signs of rejection, small pieces of 
the transplanted organ are removed for inspection under a microscope. This is 
called a biopsy.  Transbronchial biopsy (TBB) is a non-surgical procedure 
performed using a bronchoscope and special biopsy forceps designed to be used 
in the lung. During a transbronchial biopsy, biopsy forceps are used to retrieve a 
small piece of tissue from a suspicious area of the lung or airway. The tissue 
sample is then examined to diagnose lung disease. Bronchoalveolar lavage (BAL) 
is a medical procedure in which a bronchoscope is passed through the mouth or 
nose into the lungs and fluid is squirted into a small part of the lung and then 
recollected for examination. Transbronchial biopsy and bronchoalveolar lavage are 
often used lung biopsy procedures. The sensitivity of TBB for diagnosis of 
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bronchiolitis obliterans (BO) varies from 15 to 78%, and the specificity varies from 
75 to 93% in various studies [39]. BAL has not been proven useful in the diagnosis 
of chronic rejection (BO). Lung biopsy may be considered "gold standard" of 
medical diagnosis of rejection, BO and infection, but it is invasive, uncomfortable, 
costly, and often has its own associated morbidity and mortality [1]. Primary graft 
dysfunction frequently complicates lung transplant and has been an area of 
intense study [34]. The search for molecular biomarkers of acute and chronic lung 
rejection is underway. Currently biological diagnosis based on microarray analysis 
uses gene expression to predict and characterize acute and chronic rejection. 
However, the application of new genetic, genomic, and proteomic technologies is 
in its infancy for application to lung transplantation [35]. 
Noninvasive surrogates to biopsy include exhaled nitric oxide, computed 
tomography (CT), and pulmonary function testing/ spirometry [40]. Chest CT may 
not always be effective in detecting rejection [32] since the interstitial infiltrate seen 
on x-ray is hard to distinguish rejection from that of an infection. Spirometry 
provides measurement of the lung function but lacks the specifics to determine 
etiology [2]. 
Telemedicine and Home Monitoring  
Technological advancement has enabled patient care beyond the boundary of 
hospital walls. In LTHMP, data are measured by patients at their homes, then 
transmitted, and analyzed at the data center. This new type of patient care, 
referred as telemedicine, concerns performing diagnostics and delivering 
treatment to patient remotely away from the clinic using computers and 
telecommunication technologies [ 41 , 42 ]. The idea behind telemedicine is to 
provide more convenient and customized care to patients, using such technologies 
as video conferencing, smart phones, and other wireless devices to interact with 
patients in their homes. Telemedicine can provide more comprehensive and 
monitored health care at home such as remote monitoring of pulmonary function, 
blood pressure, ECG, glucose, vital data [43] and is also a logical option to reach 
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remote areas [ 44 ]. In many cases, patients are capable of performing the 
requested physiological measurements. Data communication infrastructure has 
advanced from the earlier telephone-modem, to digital communication systems 
including the internet and wireless communications that are adding convenience 
and driving down the cost of such a system. Data acquisition has been made 
easier to use with miniaturized and wearable devices, and less effort from the 
patients. Virtual home visit systems had been implemented [45,46,47] and the 
perceptions from patients were largely positive [48, 49]. In the post-lung transplant 
care, Internet-based home spirometry-monitoring [18] as well as other electronic 
monitoring programs [ 50 ] have been implemented. Telemedicine has moved 
beyond mere data transfer to the launch of novel applications like telesurgery, 
telerehabilitation, telecardiology, remote patient management and a whole 
spectrum of teleapplications [ 51 , 52 ]. “Technology innovation in healthcare 
contributes to increased independence and greater empowerment of patients as 
participants in their own medical care [53].” As the health care system moves 
further toward a patient-centered, ambulatory, and home-based approach to care, 
the use of home monitoring will become both more prevalent and more necessary 
[17]. 
From the cost perspective, home monitoring may revert expensive inpatient 
care to less expensive outpatient care. It may reduce the expenses by avoiding 
unnecessary clinic or emergency visits and the high maintenance due to late 
diagnosis. A study of cost-effectiveness of LTHMP indicated that at one-year post 
transplant, the average cost saving was about $11,000, and patient survival was 
higher in the adherent patients than in the non-adherent patients [11]. Although no 
definitive work has been performed to demonstrate the improvement in quality of 
life via home monitoring, patients are being monitored in the comfort of their home 
setting.  
Successful telemedicine implementations and induction into clinical routine 
requires well orchestrated effort. Technology, acceptance, financing, organization 
 14 
and policy and legislation, often decide the inclusion of a telemedicine program 
into daily practice [54]. The new healthcare reform initiatives have made case for 
more research on means to reduce healthcare cost at same or enhanced quality. 
For LTHMP, the demonstration of clinical utility and outcome is key to persuade 
professionals, policy makers and insurance companies about the benefit of this 
program. Therefore, this dissertation research involves a small but key component 
in this broad picture. 
Spirometry 
The Latin word spirare means to breathe. Spirometry is a pulmonary function 
test (PFT) that describes the ability of the respiratory system to move air by timed 
respiratory volumes [ 55 ]. PFT, as described in American Standardization of 
Spirometry, is an effort dependent maneuver. A subject inhales with maximum 
effort, and then blows the air out as forceful and fast as possible. Spirometry 
contains mechanistic insights into the physiologic impairment of the lungs. 
Flow/volume spirometry is routinely used for assessing the type and severity of 
lung disease in clinic. Following lung transplant, prompt diagnosis and intervention 
depends on monitoring key changes in pulmonary function [56]. "Recognize the 
(air flow) pattern, and the diagnosis will follow" [15].  
The mostly commonly used indices describing the respiratory cycle are as 
follows: 
• The forced vital capacity (FVC). A spirometric maneuver begins with the patient 
inhaling as deeply as he or she can. Then the patient exhales as long and as 
forcefully as possible; the amount exhaled in this manner is the FVC. 
• The forced expiratory volume in one second (FEV1).  FEV1 is the amount of air 
exhaled during the first second of the FVC maneuver. It tends to be lower in 
diseases that obstruct the airway, such as asthma or emphysema. 
• The FEV1/FVC ratio (FFr) is used to determine if the pattern is obstructive, 
restrictive, or normal. 
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Figure 3. Spirogram recording from Forced Vital Capacity Maneuvers  
(Source: Respiratory Physiology [57]). 
 
Note: Abbreviations slightly differ from the ones referred in this paper.  
FEV10 refers to the forced expiratory volume in one second from time zero 
(FEV1). FEV30 refers to the forced expiratory volume in three seconds from 
time zero. FEF25-75% is the same as mid flow (MEFR). 
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Figure 4. The spirometer/diary instrument. 
A spirometer/diary instrument (PFM-H100, Telemedical Inc., Minneapolis, MN, 
US) was designed for LTHMP to collect and store daily monitoring data. The 
device includes a portable spirometer along with a reusable, replaceable plastic 
mouthpiece, data input pad, digital display, internal modem, and printer [58].  
The most widely used indices that are computed from the spirogram (Figure 3) 
include forced vital capacity (FVC), forced expiratory volume at 1 second (FEV1), 
maximal mid expiratory flow rate (MEFR,  also denoted as forced expiratory mid-
flow rate or FEFR25-75, the difference of flow rates at 25% and 75% of the FVC 
volume respectively), and peak expiratory flow rate (PEFR). Measures are often 
presented as a percent of predicted (normal) value. Predicted values of FEV1 and 
FVC are based on population studies and vary by race, gender, age and height 
[59]. Spirometry features have been studied in identifying events [60]: FEV1 is the 
most frequently used index for assessing airway caliber, airway obstruction, 
bronchoconstriction or bronchodilation and provides the best estimates of airflow 
obstruction in patients with asthma, chronic obstructive pulmonary disease 
(COPD) and emphysema. It is affected only partially by subject cooperation and is 
determined both by effort-dependent and effort-independent portions of the 
maximal expiratory maneuver and often with lower variability than other variables 
derived from the flow-volume curve [61]. FEV1/FVC ratio (FFr) is another standard 
index for assessing and quantifying airflow limitation, and is also often used to 
determine if the pattern of spirometry is obstructive [60]. MEFR has been reported 
with good sensitivity for diagnosis of infection and rejection after heart-lung 
transplantation and is predictive of acute allograft dysfunction [62]. PEFR (peak 
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expiratory flow rate) is advocated and commonly used to monitoring patients with 
asthma [62,63]. A change in peak flow predominantly reflects alteration in the 
caliber of large airways as opposed to FEV1 which is affected by change in caliber 
of both large- and medium-sized airways [ 64 , 65 ]. Therefore, PEFR was 
considered indirect index of airway caliber and less sensitive than FEV1 in 
detecting airway obstructions [61]. Spirometry measures can be indicative of 
pathological processes that can often be insidious while symptoms may not be 
apparent to recipients until the transplanted organ is severely compromised [58].  
Table 1 provides definitions of a list of common spirometry variables.   
Air flow obstruction is an early sign of pulmonary rejection and is correlated 
with declines in FVC, FEV1, and MEFR [66]. Obstructive airflow is related to the 
narrowing of the airways due to bronchial smooth muscle contraction as in asthma; 
inflammation and swelling of bronchial mucosa and the hypertrophy and 
hyperplasia of bronchial glands as in bronchitis; material obstructing the flow of air 
as in excessive mucus plugging, foreign objects or tumors; destruction of lung 
tissue with the loss of elasticity and hence the loss of the external support [59].    
Restrictive airflow patterns are associated with intrinsic disorder as in 
pneumonia and tuberculosis; extrinsic disorder as in tumors, pain on inspiration, 
and pleural effusion; neuromuscular as in paralysis of diaphragm. It cannot be 
determined by spirometry alone [59]. The total lung capacity must be assessed as 
well.  
Clinic spirometry is routinely used to assess pulmonary function post lung 
transplant. Agreement between home spirometry and clinic spirometry was shown 
to be excellent [75]. Spirometry is used for early home recognition of asthma 
exacerbation in high risk patients with severe persistent disease, and for 
recognition of either infection or rejection in lung transplant patients [67]. It was 
pointed out that a fall in spirometry is seen in infection and rejection post-lung 
transplant and that the underlying disease state has a significant influence on the 
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diagnostic utility of specific spirometric indices [70]. Studies using TBB and BAL as 
gold standards have reported that the sensitivity of FEV1 for the detection of 
infection/ rejection related complications ranges from 48% to 72% in recipients of 
single lung, and 60% to 75% in bilateral-lung and heart-lung transplantation 
[68,69,70]. These results have led to the widely accepted recommendation that the 
follow-up of lung transplant recipients should include daily measurement of FEV1 
at home with a portable spirometer [18].  
In summary, studies showed acceptable performance by sensitivity/ specificity 
in the sequence of lung biopsy, clinic spirometry and home spirometry, each 
validated against its predecessor. Per ISHLT guideline, "FEV1 is the most reliable 
and consistent clinical pulmonary function test to provide an indication of graft 
function" [71].  
Table 1. Spirometry indices and definitions  
Variables Definition  
FVC Forced vital capacity; the total volume that can be forcefully expired 
From a maximum inspiratory effort (Liter) 
FEV1 Forced expiratory volume in 1 second; volume of air forcibly expired 
from a maximum inspiratory effort in the first second (Liter) 
PEFR Peak expiratory flow rate; the highest forced expiratory flow rate 
(Liter/second) 
MEFR Mid expiratory flow rate (Liter/second)  
FEV3 Forced expiratory volume in 3 seconds; volume of air forcibly expired 
from a maximum inspiratory effort in the third second (Liter) 
FEF25 Flow rate at 25th percentile of the FVC (Liter/second) 
FEF50 Flow rate at 50th percentile of the FVC (Liter/second) 
FEF75 Flow rate at 75th percentile of the FVC (Liter/second) 
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LTHMP 
University of Minnesota Medical Center, Fairview (previously known as 
Fairview University Medical Center’s or FUMC) is among the top frequented 
locations for lung transplant procedures in the United States [72 ]. The Lung 
Transplant Home Monitoring Program (LTHMP) [73], began in 1992, monitored a 
group of consented lung transplant recipients. More than 250 patients had 
participated in the research program.  
The overall aim of LTHMP was to develop a low-cost tele- homecare system 
that would detect early signs of rejection or infection. One of the research interests 
is whether it is possible to react more quickly to disease changes for lung 
transplant patients by telemetric means. The researchers have attempted to detect 
onset of bronchopulmonary infections and rejections through data review.  
In LTHMP, patients were trained to use a paperless electronic spirometer/diary 
at home to record and transmit daily vital signs, respiratory measurements, and 
symptom information. Typically, subjects would perform three forced vital capacity 
maneuvers at a consistent time in a day, preferably in the morning. The spirometer 
internally computes the values of FEV1, FVC, MEFR and PEFR of each maneuver. 
The best performing spirometry (the largest combined FEV1 and FVC values) was 
retained. This protocol ensures uniform adherence to American Thoracic Society 
standards of acceptability and reproducibility [71]. In addition, vital signs (pulse, 
weight, blood pressure, and body temperature) and respiratory symptoms 
(frequency of coughing/wheezing, amount and color of sputum, type and amount 
of exercise, shortness of breath at rest and during exercise, overall well-being, and 
stress level) were entered into the portable electronic spirometer by the subject. 
Subjects were instructed to complete a test session and transmit data back to the 
study data center [74]. Transmitted data were stored in a relational database. A 
sample home monitoring report is shown in Figure 5. 
Study nurses at the data center reviewed data records each week and 
generated triage reports that identified patients who might have signs of clinical 
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problem. The transplant clinic staff would be notified to review subjects on the 
“watch list” and took appropriate course of action including contacting the patient 
and further deciding if medication change or an in-clinic evaluation was necessary. 
Patients were typically evaluated in clinic every two months during the first year, 
regardless of the data monitoring results. Patients may be seen more frequently if 
they complain about their symptoms or health.  Patients were evaluated at a 
reduced frequency as they move farther from their transplant center or later date, 
depending on their conditions. Their clinic follow-up typically consisted of an 
annual visit, unless conditions suggested more frequent clinic contact. 
The reliability and validity of the electronic spirometer/diary instrument used as 
a patient self-measurement device has been previously established [16]. However, 
it remains a challenge to maintain patients’ adherence to regular spirometer use 
and provide data [58]; often spirometry cannot be carried out in accordance with 
the conventional quality standards [71]; adherence deteriorates over time and 
becomes more of an issue for data integrity and completeness. To ensure good 
quality data, a great amount of effort was put into evaluating factors related to 
adherence and educating patients to maintain compliance to monitoring 
requirements [58,75]. 
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Figure 5. A sample of the home monitoring report used in LTHMP.  
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Pulmonary related symptoms have been the common reasons that trigger a 
clinic visit and play an important defense role for patient safety. Symptom reporting 
is also the least invasive type of surveillance to capture events [76].  
Symptom data are subjective in nature. The following Table 2 illustrates the 
numerical coding of the respiratory symptom variables in LTHMP that include 
cough, wheeze, sputum (amount, color) and shortness of breath.  
Table 2 . Symptom data scales: cough, wheeze, sputum (amount, color) and 
shortness of breath (dyspnea) 
Symptom\ score 0 1 2 3 4 
Shortness of 
breath* (SBr) 
None Mild Moderate Severe,  
 
 
Wheeze (Whz) 0-2 /day Few hrs Several/hr Many/hr  
Cough (SBx) 0-2 /day Few hrs Several/hr Many/hr  
Sputum (SAmt) None Small Moderate Large  
Sputum color 
(SCl) 
None Watery White Yellowish Dark 
yellow/blood 
tinged 
Note: Abbreviations as in the sample home monitoring report (Figure 5)  
*: SBr at rest after exercise. 
 
Event Detection in LTHMP and Related Fields 
Qualitative Assessment 
Some related research resorts to visual display and simple heuristics to 
process home monitoring variables [77]. Information display formats including 
graphical, table, hybrid (combination of graphics and table), and control chart 
presentations were compared for effectiveness for decision-making. Such methods 
themselves do not provide quantitative assessment of the home monitored data.  
Rule Based Decision Support 
The Triage Algorithm  
In LTHMP, spirometry and symptom data were reviewed weekly by research 
nurses following expert derived guidelines known as the triage rules. Computer 
generated data summaries were used to assess data trend and compare to 
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previous data points. Human data review typically suffers from subjectivity, stress, 
fatigue, and expensive labor cost, conclusions can also differ depending on the 
reviewer.  In LTHMP, increasing number of transplanted patients and expanding 
data volumes had increased burden to the data monitoring staff, yet the resource 
is relatively unchanging. Hence, one top priority of the earlier research was to 
reduce the data burden imposed on the staff. An automated nurse triage algorithm 
had been developed.  
The basic idea of the computerized automated triage algorithm [17] was to 
compare the current week's average with the maxima of the preceding weekly or 
monthly averages. Three levels of decline thresholds were selected based on the 
starting baseline FEV1.  Similarly, the rules include heuristics based on the 
increase of existing or emergence of new respiratory symptoms. If the severity 
condition is met, a “watch alert” will be issued.  
The automated triage algorithm has been validated against the manual triage 
review and therefore, is considered an “optimal” replica of the manual triage. The 
design goal was to identify patients who should be watched for potentially having 
developed respiratory-related problems, rather than those who were actually 
experiencing an event. Because the algorithm design was not based on actual 
events, it was not valid for use in event detection. The main reasons for not aiming 
at actual event is that, to ascertain accurate event annotations would require 
dedicated professional to carefully review the paper based medical records which 
later transitioned into an electronic record system.  
One drawback of the rule-based logics is that the binary decision can not be 
easily quantified as the likelihood of event.  
Event Detection Using Bayesian Statistics 
Bayesian statistics have gained more popularity in the last decades due to that 
computation intensive solutions are widely available with dedicated software 
packages [78,79,80].  
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In LTHMP, event detection based on Bayesian statistics has been explored 
[20]. Detection was performed in an off-line setting where “epochs” - a set of 
consecutive data points of two-week length were selected from the dataset 
including half of them that end with events and half that end without events,  form 
binary trials.  This translates to approximately 10% of the data (150 two week 
epochs over 60 patient-years) utilized for training and testing. Bayesian statistical 
models, including a step function for “mean change” and a linear regression for 
“slope change” models were fit to each epoch and the probability of event was 
estimated and served the basis for event detection.  
Because these Bayesian models were trained and tested on a fixed number of 
non-overlapping epochs, the scheme is a fixed sample, trial-based detection. Each 
epoch is assumed to have a fixed duration with known event outcome, whereas in 
clinical setting, event detection must perform without prior knowledge of the epoch 
duration or outcome. Furthermore, because the models are based on the entire 
epochs, timing of detections could not be assessed.  
Detection of Change 
These time domain methods primarily concerns trend analysis in the original 
data format. In biomedical applications, a trend is seen as a general direction of 
the mean level in a set of data [81]. Trend analysis involves examining time series 
data and identifying significant increases or decreases in the magnitude of a 
reference variable [82]. Event detection is concerned about the change in trend.  
Statistical Detection of Change 
One major theoretical advance in the 1950s was to combine detection theory 
with statistical decision theory [83]. A well known problem is the change point 
detection [84].   
In general, assume a sensory response that reflects the underlying stimuli. If 
the signal is present, data observation is a combination of signal and noise. In its 
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basic form, assuming a noise distribution and a signal-plus-noise, the detection is 
performed by a statistical hypothesis testing: 
H0(Null hypothesis):             µ = µ0 =0 (noise only) 
H1(Alternative hypothesis):  µ = µs (signal and noise) 
When the cumulative probability distribution function (PDF) of µs crosses a 
specified threshold, the null hypothesis is rejected in favor of the alternative, i.e., 
the signal is present. The previously mentioned Bayesian statistics can be 
considered a special case in change detection. 
Sequential Test for Change 
A natural setting for event detection in real time is the sequential probability 
ratio test (SPRT) [85], a sequential hypothesis test developed by Wald [86]. As in 
the classical hypothesis testing, SPRT starts with a pair of hypotheses, H0 and H1 
for the null hypothesis and alternative hypothesis respectively. The next step is to 
calculate the cumulative sum of the log-likelihood ratio,  logΛi, as new data arrive: 
Si = Si − 1 + logΛi 
The stopping rule is a simple thresholding scheme: 
• a < Si < b: continue monitoring (critical inequality) 
• Si ≥b: Accept H1 
• Si < a: Accept H0 
The main challenge in statistical detections is to correctly define the signal to 
be detected and its underlying probability distribution, and modeling data traces at 
the individual subject level. 
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Signal Processing Approaches  
Signal processing methodologies depend on the applications. Many complex 
signal analysis problems are solved using frequency analysis such as Fourier 
analysis.  
Certain event of interest is detected based on known signal characteristics 
including waveform shapes and frequency signature, such as seizures showing as 
large discrete spikes, absent from a normal EEG in the electroencephalogram 
(EEG) analysis [87,88]. 
Many signals show no organized patterns. For instance, in gait control studies 
which measure the walking patterns to detect orthopedic impairment [89] and in 
heart rate variability analysis of cardiac health [90,91], the impaired or disease 
subjects are manifest with different level of regularity than the normal subjects.  
For time-dependent events, static features that are not localized in time would 
not be useful as they do not provide insight to data dynamics related to events. 
The context of event is also confined in regard to the time frame relevant to the 
event and the amount of change that can happen within that time frame. In internet 
traffic monitoring,  detection of malicious network intrusions can benefit by re-
projecting different locally observed data streams into alternate coordinates by 
using Principal Component Analysis, the components associated with the normal 
traffic and components associated abnormal behaviors could be separated [92, 
93]. 
Thus, features to be extract from the data should reflect the time frames in 
which the event of interest develops. The analysis of data correlation across 
multiple time scales can identify data patterns related to change, either temporal 
(in the time domain), or in the frequency domain, or in both.  
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C h a p t e r  I I I   
MATERIALS AND DATA SETS  
 This chapter first describes the datasets that were used as the basis to learn, 
explore and evaluate various analytical approaches, followed by the dataset used 
to validate the proposed ideas. Characteristics of the data are illustrated with 
cases.  
The Learning Set 
The Lung Transplant Home Monitoring Program (LTHMP) at the University of 
Minnesota provided the home monitoring data.  In LTHMP, patients were trained to 
use an electronic spirometer/diary device at home to record and transmit daily 
respiratory measurements, vital signs (blood pressure, heart rate, temperature, 
and weight), and symptoms [94]. Home monitoring records from 28 consecutive 
subjects with adequate length of follow-up (>60 days of spirometry monitoring) [20] 
were used. The dataset contains patient identifier, gender, date of birth, primary 
indication for transplant, date of transplant, the type of transplant, dates of the 
monitoring, home spirometry involving variables FEV1, FVC, MEFR and PEFR, 
daily temperature, and daily symptoms (cough, dyspnea, wheeze and sputum in 
ordinal scales). Data were recorded daily except for occasional gaps where 
subjects did not record or transmit data. The mean age at the time of transplant 
was 50.8 years (±SD 12.5, range 22.5 - 66.5 years) and 10 (36%) were female. 
There were 17 single lung, 10 bilateral single lung, and one heart-lung transplants. 
Home monitoring started from 26 to 367 days post transplant. There were a total of 
10,098 samples of daily records representing a total of 13,609 calendar days or 
37.3 subject-years of data where the difference in total days reflects the gap of 
days when home testing was not performed/ transmitted. The mean monitoring 
time was 1.3 years/subject (469 days/subject) (±SD 228 days or 0.8 year, range 
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60 days - 2.8 years). All subjects provided written informed consent to participate 
in LTHMP following the University of Minnesota Institutional Review Board 
guidelines.  
Table 3. Demographic characteristics of subjects 
Characteristic No. of subjects 
(N=28) 
Gender  
Female 10 
Type of transplant  
Single 17 
Double 10 
Heart-lung 1 
Pretransplant diagnosis  
Chronic obstructive pulmonary disease (COPD) 14 
Idiopathic pulmonary fibrosis (IPF) 5 
Cystic fibrosis 3 
α1-Antirypsin deficiency 2 
Bronchiectasis 2 
Other* 4 
* Pulmonary hypertension, bronchiectasis,   Eisenmenger syndrome,  
lymphangioleiomyomatosis 
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Events 
Events of interest were acute bronchopulmonary related clinical complications 
such as bronchitis, pneumonia, pneumonitis, acute rejection, and newly diagnosed 
or treated episode of an acute, primary bronchopulmonary infection or rejection 
which is accompanied by the start of a new treatment or the change of a chronic 
medication [95]. The determination of events was based on a careful review of the 
patients’ medical records for documentation of adverse effects and treatments, 
and biopsy records, or both. Events were determined by a qualified health science 
professional who retrospectively reviewed the medical records of each subject. 
The event information included patient identification number and documented date 
of the event(s). Hospitalization and telephone prescription records were not part of 
the event review. Events do not explicitly distinguish between infections and 
rejections. This research includes 10 additional events from transbronchial lung 
biopsies with graded acute rejection and infections which were maintained in a 
separate database [96]. This resulted in a total of 101 acute bronchopulmonary 
related events in 26 subjects. Events/subject ranged from 1-8 events,  and the 
median was of 2 events /subject. The remaining 2 subjects did not have events 
during the monitoring period. 
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Data Illustration and Characteristics  
The following illustrates a set of representative home monitored data series 
from the learning set. Spirometry and symptom series are displayed within two 
time frames, first by a shorter set including the first 120 days (Figure 6 and Figure 
7), then the entire set of the spirometry up to 800 days (Figure 8). In this case, two 
events were reported on day 97 and day 267. 
 
Figure 6. Illustration of the spirometry series  
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Figure 7. Illustration of the symptom reports 
(Subject X5198) 
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Figure 8. Illustration of the long term spirometry time series  
Horizontal axis is the days of monitoring, start from the first day of home 
monitoring. Vertical axis is according to the unit of each variable. 
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As illustrated in Figure 6 - Figure 8, a few important data characteristics are 
observed: 
Home spirometry data series presents a wide range of inter-day variability. 
Data are often highly fluctuating, do not look smooth and with sharp transitions 
(discontinuity), and appear noisy. Some subject’s data fluctuate significantly 
throughout the course of the monitoring. Thus, both the mean and variance could 
change from time to time. Such changing variability and complex patterns are best 
described as nonlinear which can not be represented by a linear function, and 
nonstationary whose statistical property such as means and variance change over 
time. There appears to be no periodicity.  There is also a self-similarity between 
signals in a fine time frame and a coarse time frame. This “fractal” time-scaling 
behavior is another indication of nonlinearity.  
The data variability may be contributed by numerous factors: the spirometry 
test itself, per definition, is effort dependent; there are human errors while 
performing forced expiratory maneuvers such as air leaks; there are potential 
influence of environmental changes such as the barometric atmosphere pressure; 
as well as factors that can not be enumerated for each maneuver circumstance.  
The timing of data variability in spirometry and symptom variables does not 
always align: for example, spirometry showed depressed values starting around 
day 60 (Figure 61,); while coughing and sputum were not manifest until around 
day 70 (Figure 72), and wheeze started around day 80 (Figure 8 3). In this 
example, spirometry leads the symptoms in showing earlier signs of a problem.  
Based on the learning set, there are different degrees of variability from one 
event to another event, and from one subject to another subject. Data variability 
associated with events in one subject can be very similar to that in another subject 
without an event. There is a wide range of intra- subject and inter- subject 
variability. As a result, events are not easily visible to the naked-eye. 
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The autocorrelation plots [97] indicate that: all spirometry variables exhibit long 
range dependence; the data series has deterministic component and is not 
random. In particular, the autocorrelation in FEV1 is lower than other variables at 
the same lag parameter, suggesting FEV1 requires more frequent sampling to 
capture the dynamical information.   
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Figure 9. Autocorrelation plots 
(Subject X5183) 
In summary, home monitoring data series are complex with multiple 
characteristics: data are not smooth, nonlinear, nonstationary and autocorrelated 
long range dependence; signs of events based on spirometry and symptom series 
are not necessarily manifest at the same time; and it would be challenging to 
accurately divide the series into uniform-sized “epochs” as binary trials.  
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 35 
Data Pre-processing 
LTHMP has its own data screening and correction mechanism, and the number 
of totally erroneous data points is low. No deliberate attempt was made to correct 
data points. However, data series were scrutinized for transcription errors and data 
omissions.  
Data Omissions 
These data in clinical setting, collected and reported by the patients themselves 
contain unequally spaced data points. A close scrutiny of the learning set reveals a 
wide range of monitoring completeness: from one subject reporting 301 out of 662 
days (45%) to another subject reporting 350 out of 352 days (99%). The following 
table summarizes the data omissions in the learning set. 
Table 4. Summary of data completeness in the learning set. 
  Mean ±Std 
Dev 
Min Max Median 
Total Sample days  361 201 60 1023 306 
Total calendar days 486 244 107 1421 416 
Ratio of reported days/ total 
calendar days (sample/total) 74% 16% 45% 99% 75% 
Spirometry Data 
For spirometry data, rare physiologically implausible outliers were first spotted 
and removed. The data indexing was maintained according to the calendar date.  
Symptom Data  
In symptom data, there were occasional omissions in one or more of the 
symptom frequency-severity categories for a particular day (typically less than 5% 
of available data). These missing values were replaced with the previous record 
(“last observation carried forward”) which typically contained no new information. 
However, this would permit mathematical operation such as summation on the 
available data without resetting the entire symptom categories to be missing for 
that day.  
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Symptom reporting consists of frequency and severity of cough, dyspnea, 
wheeze, sputum amount and sputum color. Unlike objectively measured 
spirometry data, symptom reports are subjectively self-reported in ordinal scales 
(Table 2). Thus, the domain expert defined heuristics are highly valued as they 
provide the best insight how to interpret the subjective data. The necessary step is 
to convert these symptom scores into a composite score.  
 By emulating the automated triage rules developed previously [17], the original 
symptom variables of dyspnea, wheeze, sputum, and cough were converted into 
one composite via weighing and summation. The weight assignment emulates the 
expert defined rules [17]. For example, the rule suggests weighing newly reported 
symptoms of dyspnea or wheeze equally to two degree increase in sputum or 
cough (e.g., from small to large amount). A moving symptom baseline is calculated 
as the average of each symptom level over an 8-week period starting 9 weeks 
before the current weekly report period and ending 1 week before the current 
report period. 
Table 5. Expert defined important thresholds (also see Table 2) 
Symptom 
Level 
threshold 
Level change 
threshold 
Cough -- 2 degree increase 
Sputum amount 3 (large) 2 degree increase 
Sputum color 3 (yellowish) 2 degree increase 
Wheezing 1 (presence) -- 
Dyspnea at rest 1 (presence) -- 
Notes: The level threshold is the minimum value of each symptom that will fire the 
alarm. The level change threshold is the minimum value of the difference between 
the current symptom value and the patient’s baseline symptom value that will fire 
the alarm. 
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The expert rule weighs the presence of wheezing and dyspnea equal to 
significant sputum or the 2 degree changes in cough and sputum over the 
baseline. Therefore, the composite symptom score is 
∑∑ += jjii ybxaSymptom ,                                                                          (1) 
where 
1=ia for xi= wheeze, dyspnea 
3
1
=ia for xi=sputum amount, sputum color, 
2
1
=jb for jy = ∆ (change) in cough, sputum amount, sputum color, over the 
baseline, respectively. 
Since symptom scores are bounded by their permissible ranges, the 
summation of the scores are also bounded without extreme values. The resulting 
symptom composite series resemble a near continuous measurement series, 
illustrated below. 
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Figure 10. Illustration of the converted symptom index 
(Subject X5198) 
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The Validation Set 
For validation purposes, home monitoring records from 30 different subjects 
between April 2007 and December 2007 that were not part of the learning set were 
disclosed to this research after the learning stage. This constitutes a new 
validation set. All subjects provided written informed consent to participate in the 
home monitoring program following the University of Minnesota Institutional 
Review Board guidelines. 
The format of the data is similar to the learning dataset. No additional patient 
demographic information was disclosed. This includes a total of 2,426 samples of 
records representing a total of 4,625 calendar days or 12.6 subject-years of data 
where the difference reflects when home testing was not performed. The average 
duration of monitoring was 148 days per subject (±SD 66 days, ranged from 24 - 
269 days).  
During 2007, an event diary was actively maintained by a dedicated study 
nurse, who followed up with physicians outside FUMC to ascertain complete 
record of events, which provides the basis of event status.  A total of 40 acute 
bronchopulmonary events were identified in 14 subjects (range 1-7 events/subject, 
median 2 events), and the remaining 16 subjects did not have events during the 
monitoring period.  
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C h a p t e r  I V   
WAVELET METHODS FOR EVENT DETECTION  
Wavelet Methodology 
Home monitored data series from LTHMP exhibit dynamical nonlinear non-
stationary characteristics with time-scaling behavior. Wavelet methods, developed 
by Mallat [98], Meyer [99], Daubechies [100,101], and Vaidyanathan [102] are 
well-suited for such type of data.  
Wavelets, meaning “small waves”, are a set of functions which are obtained by 
translating and contracting or dilating a prototype wavelet, which is an orthogonal, 
finite energy signal with compact support. This way, a wavelet transformation 
decomposes a signal, simultaneously showing its time-scale (resolution) 
representation. Intuitively, the wavelet methods are described as “seeing both the 
trees and the forest”, implying the analysis of the same signal at different 
resolutions [103,104,105].  
Tewfik and Kim [106] were among the first to discuss the decorrelation property 
of wavelet transforms for fractional Brownian motion. This decorrelation property is 
critical to perform scale dependent thresholding, known as wavelet shrinkage, 
proposed by Donoho and Johnstone [107] to reduce noise. Wavelet shrinkage is 
directly related to nonlinear regression and can lead to an optimal data recovery 
from noises [108]. Wavelet based multiresolution decomposition has proven to be 
a very effective tool to analyze nonstationary signals [109,110,111], particularly 
when noises are correlated. Although best known for image processing and data 
compression applications, wavelet has evolved over the years to be very useful in 
signal processing, trend analysis and data mining [112] and has thus been widely 
used in the fields of physiological and biomedical signal analysis to characterize 
signals [113].  
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The discrete wavelet transform (DWT) analyzes the signal at discrete 
resolutions through decomposition of the signal into successive frequency bands 
(hence, multiresolution analysis). It is more convenient to restrict τ  to dyadic 
scales τj=2j, j=0, 1, …, J. The DWT utilizes a pair of functions, a wavelet function 
ψ(t) and a scaling function φ(t) where these functions are a weighed sum of the 
scaled (dilated or contracted) and shifted version of the scaling function itself: 
)2(][)( ntnht
n
−=∑ φφ
 
)2(][)( ntngt
n
−=∑ φψ  
where a dyadic discrete wavelet scaled by 2j is defined as [114] 
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and restrict time points to integers u=1, 2, … , N.  
Applying DWT to discrete-time signal series x(t), t=1,…,n=2J, creates a 
multiresolution decomposition of x(t),  
DWT(x(t))=(aJ|dJ|dJ-1|…|d2|d1) 
of the same length n, on j octaves labeled by j=1, …,J. aJ contains the low 
frequency component of the signal, referred as wavelet approximation coefficients, 
and dJ|dJ-1|..d2|d1 contains wavelet detail coefficients at decreasing dyadic scales.  
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Further, 
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where jua , and kjd , are the DWT coefficients and  
dtttxddtttxa jukjjukJ )()(,)()( ,,,, ∫∫ == ψφ  for j=1,…,J  1; k=0,…,2j  1. 
 
In summary, the DWT signal estimation can be summarized by a three-step 
procedure: 
λfdadax IDWTkjJkjJDWT ˆ}'ˆ,ˆ{}ˆ,ˆ{ ,processing coeff.,  → → →  
which consists of decomposition process, coefficient processing, and inverse DWT 
(IDWT) reconstruction. 
 
 
Event Detection Steps 
The event detection algorithm development involved the following steps: 
wavelet-based signal analysis; feature discovery/ extraction; performance 
evaluation; and validation [115]. 
The critical step of feature extraction contains a reduced representation instead 
of the full size data input. The middle layer features (between original data and 
decisions) provide insight as to when event(s) may have occurred and serve the 
basis for event detection.  
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Wavelet Analysis of the LTHMP Data 
Choice of Wavelets 
In this research, Daubechies wavelets family was used. This choice of wavelet 
is based on the principal of “parsimony”. That is, Daubechies wavelets are 
orthonormal and compactly supported with few elements in the basis functions and 
near symmetrical; the shape of the basis function resembles the time series signal 
display in LTHMP which is not curvilinear smooth and consists of sharp jumps and 
discontinuities. In fact, in estimation of rapidly changing non-stationary signals, 
basis functions are best selected from what resembles the signal itself [116]. 
The Daubechies wavelets are denoted as dbN, by the highest number of 
vanishing moments N, db3 (top, Figure 11) was used to perform a 3-level wavelet 
decomposition (higher resolution); db4 (bottom, Figure 11) was used to perform a 
6-level wavelet decomposition (lower resolution). 
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As illustrated, the Daubechies wavelets visually resemble a local data display 
of the spirometry series. This shape similarity is one of the reasons Daubechies 
wavelets have been widely used to fit a nonlinear nonstationary signal series with 
discontinuities. 
 
 
 
 
Figure 11. Daubechies wavelets db3 (top) and db4 (bottom) 
 (Source: [117]) 
 
 
 
 
 
Scaling function                                   Wavelet function 
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Wavelet analysis was applied to LTHMP data to re-estimate signal amid noise.  
Let iy be the data series from one subject in LTHMP, at indexed time ti, to 
recover the true underlying signal nifi ,...,2,1, =  from 
iii fy ε+=                                                                                                       (2) 
with noise ε
 i. Under the matrix representations, let  
w=Hy, θ =Hf, v=Hε,  
where H is the dyadic orthonormal wavelet transformation matrix, let jiθ be the 
wavelet detail coefficient of the true signal fi at time i, scale j and jiw and jiv defined 
similarly for the observed data and the noise, respectively. Due to the orthogonality 
of the DWT,  
j
i
j
i
j
i vw +=θ . 
The wavelet approximation coefficients were kept intact as they represent low-
frequency deterministic component representing the temporal trend in the signal.  
Let iw =(w1,w2,…,wn)’ be the wavelet coefficients from w= Hy, and let the noise 
term ii z⋅=σε , where zi is independent Gaussian random noise with mean zero 
and variance one, one computed an estimate of σ, the standard deviation of the 
noise from the wavelet coefficients iw . 
A shrinkage rule (.)Tδ (“WaveShrink”) [118] was then applied to the coefficients 
of wi. Each wavelet detail coefficients wi was rejected or retained into iwˆ  per 
threshold T 



>−
≤
=
TwifTwwsign
Twif
w
iii
i
iT ||),|](|[
||,0)(δ                                                            (3a) 
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The Universal Threshold T [119] is defined as 
)log(2 nT σ= ,                                                                                               (3b) 
where n denotes the signal length, and σ denotes the estimate of the standard 
deviation of noise, given by 
6745.0
MAD
=σ ,                                                                                                     (4) 
where the MAD is the median absolute deviation of the wavelet coefficients 
estimated in the first scale and the factor 0.6745 is used for calibration with the 
standard Gaussian distribution. The universal threshold method involves less 
computing cost, relatively simple, and would produce a “noise-free” estimate as for 
a wide range of n, the expected number of coefficients exceeding the threshold is 
relatively low and T  is optimal with random Gaussian noise [120].  
Let θ  be the noise free true wavelet coefficients, under the orthogonal wavelet 
transform, one has 
),(),( 22 nT INHHNw σθσθ == ,  
Because of orthogonality of H, the inverse DWT (IDWT) is simply given by f = 
HTθ . Therefore, by thresholding or shrinking the detail coefficients and inverting 
the DWT, we eliminated v and obtained fˆ , an estimate of the underlying signal f. 
the “WaveShrink” estimate can be written as 
nkniwhf
k
kkii ,...,2,1;,...,2,1,ˆˆ ===∑                                                                     (5) 
and 
∑=
k
kkii wEhfE )ˆ()ˆ(
, 
∑=
k
kkii whf )ˆvar()ˆvar( 2
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The indexing of sequential data points is maintained by ti, i=1,2,…, n..  It is 
necessary to preserve the correct data spacing so that the time-scale relationship 
is protected. The basic approach is to map unequally spaced data to a regular grid 
[121,122], and the unobserved consecutive data points were linearly interpolated 
between two known data points. Then wavelet shrinkage and reconstruction per 
the inverse wavelet transformation were performed as previously described. Data 
indices corresponding to the interpolation were tracked and event detection would 
not occur at these indices. 
Illustration of Wavelet Method  
The wavelet decomposition overcomes the issues of autocorrelation which 
results in nearly uncorrelated components in the wavelet space.  
Two figures (Figure 12 and Figure 13) illustrate such effect. First, a four-level 
DWT was performed on the FEV1 data. Figure 12 shows the original data series, 
followed by the DWT decomposition. FEV1 was decomposed into approximation 
A4 and detail coefficients D1, D2, D3, and D4. The lower numbered scales give 
the details corresponding to the high frequency components of the signal and the 
higher scales correspond to the low frequency components. DWT identifies those 
larger coefficients that are most significant for representing the data, which are to 
be separated from noise related small coefficients. 
Figure 13 shows the approximation coefficients (A4) has slowly decaying 
autocorrelation, which represents the deterministic component in the data. The 
autocorrelation in the wavelet detail coefficients in each scale quickly decays and 
becomes nearly uncorrelated (shown in D1-D4). This decorrelation property is 
critical as this is the direct result of the decomposition process.  
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Figure 12. Data series FEV1 and its four-level decomposition  
Each vertical bar indicates the position and amplitude of the corresponding 
wavelet coefficients. Scales are 2J-1, J=1,2,3,4. (Subject X5183). 
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Figure 13. Autocorrelation function (ACF) - lag plots of wavelet coefficients.  
ACF-lag plots of A4, D1-D4 at scale 2J-1, J=1,2,3,4. (Subject X5183). 
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Wavelet Improves Signal Noise Ratio 
The wavelet method provides excellent noise removal choices by retaining only 
significant wavelet coefficients. Inverse wavelet transformation reconstructs from 
the reduced wavelet space as the de-noised signal estimate. This is illustrated 
next. 
Data estimation by wavelets and by a moving average of a sample FEV1 series 
is shown in Figure 14 [Panel A]. The signal noise ratio (SNR) was computed and 
compared ([Panel B]) with a sliding window size n=20 and an updating block size 
nx=2. It is shown that SNR by wavelets(DWT) is consistently higher than that of a 
moving average approach (MA). The wavelet estimate closely traces the data 
points, with no phase shift, and it is not over influenced by noisy outlying 
observations. The moving average estimate provides a reasonable fit but it 
noticeably deviates from the center of data points at times. Throughout the 
sequence, the SNR by wavelet method is consistently higher than that of the 
moving average method, the grand mean (± SD) SNR were: SNRMA: 12.06 ± 4.26; 
SNRDWT: 19.15 ± 7.21; and SNRDWT/SNRMA =1.76 ± 0.89. SNRDWT is superior to 
SNRMA. Therefore, this example shows the benefit of wavelet regression versus a 
single scale moving average. 
The improvement in signal-noise-ratio over a simple averaging approach is no 
coincidence: multiscale filtering using wavelets generally outperforms monoscale 
methods such as mean filtering and exponential smoothing for data that contain 
features localized at multiple scales [123] where data show jumps, spikes, and 
discontinuities as observed in LTHMP.  
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Figure 14. Signal Noise Ratio per DWT and MA  
A: The upper figure shows the data sample points (connected with solid lines “—“); 
a wavelet filtered estimate “---”, and a simple moving average filtered estimate “---”. 
 
B: The lower figure shows the signal noise ratio estimate for a wavelet method “---” 
and for a moving average method “---”. 
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Wavelet Multiscale Analysis 
The Maximum Overlap Discrete Wavelet Transform (MODWT) [124], was used 
to simultaneously inspect the scale-dependent signal behaviors. MODWT is an un-
decimated modification to DWT which is therefore time shift invariant, i.e., a 
translation in the signal will result in a translation of wavelet coefficients by the 
same amount [125]. Therefore, MODWT aligns wavelet coefficients at each time 
point with the original data index so one can simultaneously analyze localized 
signal variation with respect to scale and time, and the temporal relation to events.  
This is particularly useful as an offline analysis, which can approximately 
estimate the event onsets corresponding to the event records, and in turn can 
estimate an appropriate event window size for detection classification. 
Figure 15 illustrates an MOWDT analysis. The signal and time-dependent 
variations at each detail scale were examined simultaneously. Scale dependent 
signal variations stood out as the potential features related to the events. As 
highlighted in the boxes, prior to events, there was increase of variations at these 
fine scales, on top of a declining trend (shown as arrows). These behaviors are not 
easily seen in the single scale methods. From this illustration, the FEV1 started to 
decline from the recent peaks (panel C) along with fine scale signal variations 
(panel B) at approximately 13, 8, and 17 days prior to their corresponding event 
records. Therefore, event onsets were approximated as having started 2~3 weeks 
prior to the corresponding event records.  
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Figure 15. Estimating Event Onset and Defining Event Windows Using MODWT. 
A: signal series with events, unfilled data points are linearly interpolated and 
shown with circles. B: Wavelet details plots (D1-D3); C: The denoised signal. 
The red vertical line represents events records. The vertical boxes are 
approximate timing of event onsets.  
(Subject X3033) 
 
Computational burden of the DWT is in the order of O(N) and O(Nlog2N) for 
MODWT, this is quite acceptable for practical use since they are at the same order 
of FFT (Fast Fourier Transform) (O(Nlog2N)) or less.  
Wavelet analyses were performed in MATLAB 7 computing environment with 
Wavelets Toolbox [126], user-developed Wavelab [127], and wavelet methods for 
time series [124]. 
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Event Feature Extraction - A CUSUM Approach 
Feature refers to a distinctive trait of the data. The data represent patients in a 
clinical setting who have unique disease history and unique reaction to lung 
transplants, showing wide range dynamics in their home monitoring data. Because 
individual response to disease process is complicated and not stereotypical 
between subjects or even between events in a single subject, the data pathway is 
unpredictable. Because no characteristic data patterns could be identified as event 
templates, event feature extraction warrants a data driven approach. 
Through wavelet multiscale analysis of each and every spirometry variable 
data series of each subject, it was identified that unusual scale-dependent data 
variation amid a declining trend indicated events. The near term decline could be 
highlighted by subtracting a signal from the longer term trend as the reference, 
showing as “crossovers”. This idea is also consistent with the clinical guidelines to 
diagnose pulmonary diseases by comparing current spirometric readings to the 
previous readings to assess transplant status or disease progression [71].   
Selection of Resolution Parameters 
Through case analyses, a resolution scale of 23 days traced data closely. A 
scale of 26 days produced slow evolving trend that can serve as a moving 
reference. In general, crossover occurs more frequently when the scales are 
closer, with the extreme scale of 20 (raw data points) crossing over the reference 
constantly.  
These choices of resolutions are similar to the parameters in the automated 
triage rules [17] in which moving average window sizes of a week is roughly 23 (8) 
days, and 2 months is roughly 26 (64) days, which also gave some assurance of 
these scale choices .  
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CUSUM of Signal Crossover for Event Detection 
The CUmulative SUM (CUSUM) method, first described by Page in 1954 [128], 
is based on sequential monitoring of a cumulative performance measure over time. 
A sequential detection scheme is preferred in real time detection problems. The 
CUSUM methodology has emerged as a suitable method for physiological 
monitoring [129] and healthcare outcomes [130].  
The idea of CUSUM is connected to a simple integration of signal over its 
target values to reveal a level shift over incremental samples. Such multiresolution 
signal and cross comparison has become a common theme in real time 
physiological data monitoring where measurement of sharp changes is contrasted 
with long-term trends (denoted in some literature as “offset”) [131].  This is suitable 
for on-line monitoring and event detection, regardless if changes are abrupt, rapid, 
or incremental. It is also a standard method in biomedical signal research to realize 
the event onset detection by defining the response onset as the point where the 
observed signal passes a certain threshold [132]. The CUSUM approach converts 
a fluctuating signal into a monotonic function, and prevents detection 
inconsistency, i.e., in alarm or out of alarm due to fluctuation of data around the 
threshold. Hence reliability is assured and the false alarm rate is controlled. 
A CUSUM-based sequential event detector was therefore constructed. It is the 
running total of the differences between the signal and the reference, as previously 
described. The CUSUM is directional since only the one sided crossover indicating 
a declining pulmonary health is used in event detection. 
Assume a process where the signal si is above E(si), the CUSUM statistics is 
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at sequential time point ti, i=1,2, …k. E(si) is the reference and si is the signal as in 
the wavelet analysis. siu and siv  are the variance terms, from the wavelet analysis 
at resolution u and v. 
Alternatively, this may also be written in the form 
Ck =max(Ck−1 + si − E(si), 0)                                                                                     (7) 
C0 =0, 
where i=1,2, …k, for si − E(si). 
Note in this application, a signal si below reference E(si) is of interest, as 
opposed to the conventions above, one only needs to rectify the signs accordingly. 
In Figure 16, Panel A shows the data points x[ti], wavelet estimated signal and 
reference. Panel B shows the subtraction of signal from the reference and the 
crossovers; Panel C shows the cumulative crossover, with the one-sided sections 
highlighted.  
Given the signal series x=[xtx, xtx+1, …, xtx+k] and the reference series y=[ytx, ytx+1, 
…, ytx+k] with crossover at tx , the one-sided cumulative sum Sk at time k is  
(1) ∑
=
=
k
i
ik dS
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 = −
+
∑ − )( i
it
i yx
x
,  
where di is the difference of xi (signal) and yi (reference), i=1, .., k, −− )( ii yx is the 
negative portion when xi  < yi  at time instant i, and the positive portion of the 
crossover is back calculated as  
(2) ∑
−
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it
i yx
x
,  
where i=0, .., − k’, +− )( ii yx is the positive section when xi  > yi  at time instant i.  
For simplicity, CUSUM refers to Ssign(k), where the sign indicates the one-sided 
CUSUM of interest. 
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Figure 16. Illustration of signals, signal crossover and CUSUM of crossover for 
event detection.  
From top to bottom: original data “---”, signal(x “---”) and reference(y “---”) 
estimates (Panel A); crossover (one-sided “---”, Panel B); cumulative crossover 
(one-sided “---”, Panel C).  
 
The initial CUSUM is set to zero. Once the signal crosses downward over the 
reference (xi < yi), the CUSUM starts to compute by summing up all the difference 
at each sample point i over the entire area under the curve (between 0 axis and xi 
− yi) as long as xi < yi. The CUSUM reaches its maximum when the signal upward 
crosses the reference (xi > yi) and is reset to zero. Once the next downward 
crossover occurs, the negative CUSUM starts computing again while the positive 
CUSUM is back calculated from the point of crossover. This way ensures 
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continuity at the crossover point. The one-sided CUSUM is further just referred as 
“CUSUM”. When the CUSUM exceeds a pre-specified threshold valueΤ, the alarm 
sets off.  
Because CUSUM is an integral form of the input series over time unit (day), its 
unit is [input unit-day], e.g., [Liter-day] for FEV1. For brevity, we do not further 
specify the CUSUM unit. 
Thus far, a single input vector x ∈ R1 has been derived into a CUSUM vector v
∈ R1, where v[ti]  = f(x[ti]), at time ti, i=1,2,3,...,n. Denote v as a “classifier” and the 
magnitude of each waveform v will be used in classification. The corresponding 
classification rule compares v to a predetermined threshold T(T<0) at each time 
instant, i. The event detection has thus been converted to a sequential detection 
problem.    
The CUSUM classifier can be also viewed as if one starts scanning of signal at 
the current time backwards, until the CUSUM reaches a threshold, like a neighbor 
clustering for a spatial statistical analysis [130].  
For detection using symptom converted score, the same CUSUM approach 
and computer code developed for the spirometry were applied. It is to be noted as 
opposed to spirometry, an increase in symptom is a sign of problem. By assigning 
a negative sign to the symptom series, the one-sided crossovers were used, 
consistent with those of spirometry. 
The following illustrate event detection using CUSUM applied to symptom 
series. 
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Figure 17. Illustration of symptom-based event detection. 
Horizontal axis is the days of monitoring;  
A : Data series is the symptom composite. The data points are dark dots (“.”),  
missing value replacement are red dots (“.”) with signal (“---”) and reference(“---”). 
B : Difference between the signal and reference (crossovers) (one-sided); Small 
vertical lines marks 2,3 weeks prior to events and one week after events.  
C : The one-sided cumulative crossover(“---”). The horizontal lines (“---”) are grid 
lines to determine if a threshold has been crossed. 
Short vertical lines in B and C mark 2 weeks and 3 weeks prior to-, and 1 week 
post events.  
 (Subject X5153) 
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Figure 18. Summary of the Wavelet-based Detection  
    
   
 
 
    
 
Summary of the Wavelet-based Detection  
 
1. Select an input signal (e.g., FEV1) time series vector x=x(ti), i=1,2,…,n . 
   a. Perform wavelet decompositions on x, at two resolution levels: 2J days, 
J=3,6. Use Daubechies wavelets db3 for J=3 and db4 for J=6, respectively. 
   b. Obtain wavelet coefficients w. Apply noise elimination with Universal 
Threshold formula ( )log(2 nT σ= ) to reject or retain w.      
    c. Inverse wavelet transform from denoised w’ resulting in smoothed signal 
vectors corresponding to high resolution (y1) and low resolution (y2). 
2. Identify crossovers at points xt where 0)()( 21 ==− txxx dtyty . Subtract y1 from y2  
3. Calculate cumulative sum (CUSUM kS ) : 
∑
=
=
k
i
ik dS
1
, for k points where id  <0 corresponding to a decline. 
4. Obtain a CUSUM time series vector v =v(ti), i=1,2,…,n to be classified.  
(MATLAB code in Appendix D) 
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Classification and Performance Evaluation 
The performance metrics include the detection probability (sensitivity), the false 
alarm rate, and the timing of detection, following studies of continuous detection 
problem [133 ,134 ,135 ]. These metrics slightly differ from those of a binary 
outcome diagnostic test as in Table 6 below. 
Performance Metrics 
For binary classifications, a confusion matrix (“contingency table”) below 
illustrates the classification of the testing samples. The true positive rate is 
TPR=TP/ N+ and the false positive rate FPR= FP/N–. 
Table 6. Confusion matrix of a binary classifier 
 Test Positive Test Negative Total Samples 
Positive 
case 
True Positive  
(TP) 
False Negative 
 (FN) 
 
N+ 
Negative 
case 
False Positive  
(FP) 
True Negative  
(TN) 
 
N– 
Sensitivity  
Sensitivity is the probability of true detection and is computed as the proportion 
of events that have been correctly identified by the detection algorithm.  A true 
detection generates an alarm within the time frame associated with the event, i.e., 
an event window (also denoted as “signal occlusion period or SOP” in seizure 
detection literature).  
Sensitivity is the same as the true positive rate (TPR)=TP/N+. which can be 
normalized by the  total monitoring duration -  a constant value for the given data 
set, expressed as number/subject-year. 
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False Alarm Rate (FAR)  
A false alarm is an alarm in absence of an event. If detection occurs outside of 
the event window, it is a false alarm (” false positive” ). The false alarm rate (FAR) 
is defined as the number of false alarms divided by the total monitoring duration, 
expressed as number/subject-year.  
FAR=FP/Duration 
FAR is not the ratio of false alarms over all alarms as reported in some 
research.  
True Alarm Rate (TAR) 
Similar to the definition of FAR, one obtains TAR as 
TAR=TP/Duration=Sensitivity× N+/Duration= Sensitivity ×const. 
 
Specificity 
Specificity is defined as the probability of testing negative given a negative trial 
in a binary testing scenario (TN/N–). Specificity is not well defined in sequential 
testing problems as there are infinite ways to segment data into individual trials. 
However, given FAR, one can estimate specificity per a procedure discussed in 
section “Approximating ROC”. Since a high FAR indicates low specificity, 
specificity is inversely related to FAR.  
Event Window for Classification 
Classification is made by comparing the timing of detection to the 
corresponding event records. As previously illustrated in Figure 15, wavelet 
multiresolution data display and examination provided valuable insight to estimate 
event onset. As the event types are acute pulmonary-related in nature, on 
average, an event window was estimated to start typically within 2~3 weeks prior 
to the corresponding event records. Therefore, two clinically feasible window sizes 
were used: 1. An event window starts 2 weeks prior to event, and ends 1 week 
after event. 2. An event-window starts 3 weeks prior to event, and ends 1 week 
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after event. A fixed window size is only approximation, as quite often in medicine, 
the exact knowledge of event onset and its resolution is unknown, and sometimes 
only post hoc [136]. The remaining segments are defined as non-event related. 
The data series were thereby labeled with event status consistently for all input 
series prior to classification.  
Classification 
The following illustrates a representative event detection and classification 
scheme. Figure 19 shows the CUSUM sequences and their temporal relationship 
with the events (red vertical lines). Alarms are generated depending on whether 
the threshold line is crossed. 
Most classifications are straightforward. By scanning the time series from left to 
right, the first CUSUM that exceeds a predetermined threshold will trigger 
detection. A detection occurs within the event window is a true detection. The true 
detections are marked by “✓ ” symbols (1-6 except for 4”7”). Subsequent 
detection of the same event by CUSUM 2 is not recorded as a new detection and 
only one count of a true positive was recorded. Certain classifications may depend 
on the event window size (marked by “✓?” at 5 where a wider window would 
classify 5 as true vs. a narrower window would be false). Multiple false positive 
detections could happen consecutively and each would be counted as one false 
positive.  
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Figure 19. Illustration of event detection and classification through CUSUM.  
 
To summarize, the CUSUM are classified per the following rule: 
 
Figure 20. Classifying CUSUM.
Classifying CUSUM  
 Max(one-sided CUSUM) > |T| generates a detection. 
 Detection within event window is a true positive and outside event 
window is a false positive. 
 If a CUSUM detects an event at threshold |T|, it is detected at |T’|<|T|. 
 There is at most one true detection for each event, which can be 
detected by a subsequent CUSUM. 
 Each false positive was counted as a separate false positive. 
 If a false CUSUM was more than 6 weeks wide, two false positives 
were counted. 
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Operating Characteristics (OC) 
The performance of a detection algorithm is characterized using an Operating 
Characteristics (OC) curve consisting of sensitivity versus false alarm rate. This is 
a well documented approach involving continuous monitoring [133,134,135] and 
seizure detection in EEG analysis [137,138]. OC curves are constructed by plotting 
the sensitivity and false alarm rate as a function of the detection threshold T. A 
range of threshold levels were selected (shown as gridlines in plots) that would 
generate sensitivity between 0 and 1. The OC differs from the Receiver Operating 
Characteristics (ROC) in which the sensitivity and specificity are computed for 
discrete testing scenarios. The predicted best threshold T for future testing is 
selected by a tradeoff between A) maximizing sensitivity in detecting events, and 
B) minimizing the false alarm rate. 
The plots were produced in Microsoft Office EXCEL 2003, Chart Wizard XY 
scatter plot.  
OC Weighting: Per-event and Per-subject  
The OC performance was calculated according to the two ways of weighting: 
“per event” and “per subject”. In the per-event weighting, all events are equally 
weighted regardless from which subject. The sensitivity is the number of detected 
events divided by the total number of events. In the per subject weighting, the 
sensitivity is first calculated for that subject, and then averaged across all subjects. 
The per subject metric potentially avoids being overly influenced by a particular 
subject with many events.  
Similarly, false alarm rate is calculated in two ways: the total number of false 
alarms divided by the total subject-years is denoted as “per event false alarm rate” 
(number/subject-year); the total number of false alarms divided by each subject-
year, then averaging across all subjects is denoted as “per subject false alarm 
rate” (number/subject-year). 
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Approximating ROC 
OC provides complete and unbiased performance metrics for the detection 
problem. However, ROC is the conventional metrics and this section describes the 
conversion of OC into ROC so one can also interpret the performance in the 
conventional terms.  
Consider the monitoring dataset containing a total of N segments, of which N+ 
are identified with events. Let this group be denoted by C1, and let the group of the 
remaining N–=N – N+ not associated with events be denoted by C2. For the mth 
monitoring variable, its detection performance is calculated by OC previously 
described. Recall an ROC for diagnosis is constructed by varying the threshold cut 
point.  
Let jpˆ be the maximum of the CUSUM sequence vj , j∈Z, and z the threshold 
cutoff. For each cut point z, the following quantities can be computed: 
)ˆ(
)ˆ(
zpIY
zpIY
j
j
<=
≥=
                                                                                                (8) 
where I(.) is an integer indicator function that the one-sided monotonic CUSUM 
sequence results in either Y=1 and Y =0 or Y=0 and Y =1. 
−
+
∋
∋
∋
∋
=−
=
<=
≥=
<=
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∑
∑
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zpI
zpI
zpI
zpI
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Cj
j
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j
Cj
j
Cj
FP(z)SPEC(z)1
POS(z)SENS(z)
)ˆ(FN(z)
)ˆ(FP(z)
)ˆ(NEG(z)
)ˆ(POS(z)
1
2
2
1
                                                                                (9) 
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POS(z) = the number of true positive detection at threshold cut point z; NEG(z) = 
the number of true no detection at z; FP(z) = the number of false positive detection 
at z; FN(z) = the number of false negative detection at z; SENS(z) = sensitivity or 
the probability of true detection; 1 − SPEC(z) = the probability of false detection. 
As the relationship between false alarm rate (FAR) and FP(z) holds as 
FAR=
NindowWDuration ⋅
=
FP(z)FP(z)
                                                                     (10) 
for an average window size indowW .  
However, the reverse process does not hold since there are infinite ways to 
segment the data series, and each ROC depends on the segmentation. As 
previously explained, since one does not have the exact knowledge of event onset 
and resolution, one could not accurately and realistically perform segmentation 
upfront. 
Therefore, OC(SENS(z), FAR) for the sequential detection scheme is 
approximately equivalent to a conventional ROC (SENS(z), 1 − SPEC(z)). One can 
also discuss the performance in the conventional terms in ROC. The test statistic 
based on the area under the curve )(zA  [139] 
))((
5.0)(
zASE
zA −
                                                                                                      (11) 
which follows a standard Gaussian distribution with mean 0 and variance 1.  
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Timing of Detection  
One important component in evaluating an event detection algorithm θ is the 
timing of the detection τ, which is defined as the earliest time ta when CUSUM 
classifier Sk crosses the threshold T, compared to the event time te. For a 
detectable event θ, the alarm time ta is  
ta=min{k: |Sk|> |T|}.                                                                                                   (12) 
)|( θτ ae ttE −=                                                                                               (13) 
A time τ>0 is “early warning” since the day of detection is prior to the day of 
corresponding event documentation. In the case of a late detection where ta > te, τ 
<0 represents a delay in detection.  
0 10 20 30 40 50
-5
-4
-3
-2
-1
0
1
2
3
Monitoring Day
CU
SU
M
 
o
f T
re
n
d 
D
ev
ia
tio
n
Advance Notificatio Time (tau 1) @ T1
tau 2 @ T2
Event
 
Figure 21. Timing of detection τ and early detection. 
At threshold cutoffs |T1| < |T2|, the timing τ1 > τ2, i.e., sooner detection with lower 
cutoff values. 
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Results 
In results, representative cases are first illustrated. In particular, a case with 
detailed event diary is used to provide connection between detection and clinical 
insight.  
The overall performance including all subjects is summarized by the Operating 
Characteristic (OC) curves. Then the performance is further evaluated under the 
validation set. 
Case Illustrations 
A Case with Event Diary 
A representative case with detailed event diaries is illustrated next.  This is a 
single lung transplant male subject who had experienced two events within 250 
days of follow-up. Clinical information is annotated chronologically with the FEV1 
home data. 
 Figure 22 shows how the detection works under the signal crossover method. 
The wavelet estimate of FEV1 clearly indicates that about 2~3 weeks prior to each 
event, the data trended lower and crossed the reference, initiated a crossover. 
This crossover continued and the CUSUM increased and peaked about 4 and 5 
days post the two events, respectively. The second detection would be classified 
as a false alarm due to lack of qualifying event documentation. This example 
contains insightful annotations to support our contention that the crossovers were 
indeed related to events and did not occur randomly. 
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Figure 22. A case illustration of event detection based on FEV1. 
A: Data points, signals and events: original data points “.” and interpolated data 
points “.”, signal ( “—“) and reference ( “—”) [L];  
B. Signal crosses over the reference (“—“, one-sided);  
C. CUSUM(“—”, one-sided). The long vertical lines indicate events.  
B&C. Short vertical lines mark event window sizes of 2 weeks and 3 weeks prior 
to-, and 1 week post events to classify detections. The light blue grid lines in C “—“ 
are grid lines which serve as thresholds. 
(Subject X3020) 
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The event diary for this subject annotated the follow-up information which 
details the situation surrounding these events: 
①   Event 1. “Subject had bronchoscopy (day 123) -cultures showed moderate 
Pseudomnas growth” (event). 
②    “Subject called after finishing Ciprofloxacin which made him "tired”, he still 
has not recovered and has fatigue, slight shortness of breath (SOB), “sniffles" for 
2 weeks.  Has not seen his physician.  Physician ordered labs including Prograf 
(Tacrolimus), CMV PCR, CBCP, electrolytes, and nasopharyngeal swab for RSV 
and viral culture.  Subject was reminded to evaluate his clot and stopping 
warfarin.  All orders faxed directly to subject so he may expedite process. “ 
A. Nurse note shows absence of event (day 161): “PCP (primary care physician) 
visit in emergency room - saw PCP for sore throat - no Tx (surgical procedure) or 
Rx (medical treatment)”.  
B. Physician note shows absence of event (day 164): “FEV1 trend down & 
increased symptom/severity; Had patient see PCP, exam negative.  Physician 
ordered NSP for RSV and culture, labs.  RSV negative, CX(chest x-ray)  pending.  
Labs stable. FEV1 level slightly low and dose adjusted.  Subject felt he was more 
SOB in AM with cough, but by 12 noon he was less SOB and not coughing.  If he 
did not get better or numbers did not go up, physician would ask that he came to 
clinic two weeks later for clinic and bronchoscopy”.   
③   Event 2. Nurse note (day 212): “Upper respiratory sinusitis - amoxicillin 
provided and no other treatment.” 
This case also indicate a “false” alarm, associated with ② per strict event 
definition in this study, which would still be clinically meaningful as an emergency 
visits was initiated.  
 
Note: Prograf,  PCR, CBCP, electrolytes, warfarin, Ciprofloxacin, etc., all refer 
to medical regimens. 
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The following illustrates event detection under considerable proportion of data 
omissions. As in Figure 23, there were 292 days of observations among 526 
calendar days of monitoring (44% unfilled calendar) and the event detections. Data 
omission may affect detections in varying degrees, but in this case, the CUSUM 
sequences were correctly generated in 7 out of 7 events (100%) with few incorrect 
sequences.  
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Figure 23. A case with data omissions in the learning set. 
A: Data points, signals and events; B: Crossover; C: CUSUM (one-sided) 
Labels are identical to previous plot. Omitted data points were interpolated as the 
red dots in the top plot.  
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The following is a case in the validation set which also involved many omitted 
data points. There were 51 observations among 232 calendar days of monitoring 
(78% of calendar with no data). All CUSUM sequences were correctly generated in 
6 out of 6 events (100% sensitivity).  
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Figure 24. A case with data omissions in the validation set 
A: Data points, signals and events; B: Crossover; C: CUSUM (one-sided) 
Labels are identical to previous plot. Omitted data points were interpolated as the 
red dots in the top plot.  
(Subject X3032) 
Although these apparent successes might be due to the fact that this is a 
retrospective analysis where the data interpolation took advantage of data values 
made available at a later time, they also seem to suggest that data omissions that 
did not alter the trend would not severely impact the detections. 
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The Undetected Events 
Certain events were undetected. The following describes the details of these 
undetected events using FEV1 as the detection variable. 
Of the 101 events in the learning set, 86 events would be detectable simply by 
adjusting the detection threshold (|T| ≥ 0.1). However, 15 events would  not be 
detectable: in 10 events, the signal lines were above the reference lines (example 
shown in Figure 25) and crossover did not occur; 2 events were considered to 
contain critical data missing which were attributed to the events; in 1 event, both 
the raw data points and the signal line are ascending, which is exceptional to the 
basic assumption that events must be manifest with a decline in FEV1; in 1 event, 
the data points jitter around a flat line which resulted in no CUSUM; in the last 1 
event, there was a single observation of large decline in value which does not 
contribute to enough CUSUM for detection at |T| ≥ 0.1. Therefore, no triggering of 
crossover would be the main cause of detection failures.  Cases are illustrated 
next in Figure 25 and Figure 26.  
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Figure 25. Case illustration: A missed detection 
A: Data points, signals and events; B: Crossover; C: CUSUM (one-sided) 
The signal line is above reference line, crossover never occurred, whereas all other 6 events were detected. 
(Subject  X5153) 
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Figure 26. Case demo: A missed detection due to lack of data (missing data around the event).  
A: Data points, signals and events; B: Crossover; C: CUSUM (one-sided). The interpolation to replace the missing 
data points, shows a flat line, did not generate crossover. (Subject 5170) 
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Performance Evaluation – Results from the Learning Set 
Case illustrations show that detection algorithms work with varying degree of 
effectiveness for each subject. This section collectively reports the detection 
performance in all subjects involved in the learning set. 
Operating Characteristics (OC) 
To compare the overall performance of individual variables, one OC curve is 
constructed for each variable. A set of threshold values were selected for the 
cases in the learning set. The set of threshold value was independently chosen for 
each input variable, with some values overlap. To interpret the OC, for example, as 
the threshold |TFEV1| decreases from 2 to 0.1, the sensitivity and FAR increases, 
labeled as ①-⑥ in below and in Figure 27.  
|TFEV1| 2 1.5 1 0.5 0.25 0.1 
Sensitivity 0.446 0.554 0.624 0.802 0.871 0.931 
FAR 1.56 1.88 2.49 3.81 5.36 6.60 
Label ① ② ③ ④ ⑤ ⑥ 
 
Univariate OC’s are plotted in the same plot, first by “per event” then by “per 
subject”. 
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Figure 27. Operating Characteristics, per event. 
Notes: Symptom: derived symptom index (page 37).  
Axis on the right: True Alarm Rate (TAR), where TAR=TP/Duration=Sensitivity× 
N+/Duration = Sensitivity×(101/37.3)= Sensitivity×2.71. One can easily convert the 
scale of sensitivity to TAR, e.g., an 80% sensitivity = 2.2 TA/pt-yr. 
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Figure 28. Operating Characteristics, per subject. 
A partial area region is illustrated by the dashed lines which confine region:  
Sensitivity [0.5-1] and False Alarm Rate [1-6]/subject-year, where the partial “under 
the curve” (pAUC) is the proportion within the region. 
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Table 7. OC performance, per event 
 FEV1 FEV1/FVC MEFR PEFR Symptom 
|Tk| S FAR S FAR S FAR S FAR S FAR 
0.05 -- -- 0.911 6.57 -- -- -- -- -- -- 
0.1 0.931 6.60 0.852 5.71 0.921 6.97 0.905 7.75 0.979 6.95 
0.25 0.871 5.36 0.801 4.81 0.862 5.66 0.900 6.68 0.969 6.12 
0.3 0.851 4.83 0.723 3.57 0.823 5.15 0.891 6.20 0.969 5.74 
0.4 0.812 4.29 0.624 3.11 0.782 4.75 0.882 5.90 0.958 5.66 
0.5 0.802 3.81 0.554 2.63 0.721 4.40 0.882 5.55 0.948 5.47 
0.75 0.693 3.11 0.515 2.17 0.681 4.08 0.853 5.20 0.865 4.80 
1 0.624 2.49 0.366 1.56 0.614 3.57 0.781 4.72 0.823 4.26 
1.5 0.554 1.88 0.267 1.15 0.485 2.33 0.714 3.78 0.757 3.62 
2 0.446 1.56 0.168 0.78 0.444 1.72 0.635 3.35 0.729 3.06 
3 -- -- 0.139 0.46 0.317 1.15 0.481 2.25 0.650 2.55 
3.5 -- -- -- -- -- -- -- -- 0.555 1.82 
pAUC 0.433 0.344 0.326 0.280 0.471 
Notes: S: Sensitivity (%event); FAR: False Alarm Rate(#/subject- year); “--“ not 
evaluated. pAUC(0-1): partial area “under the curve”.  
Table 8. OC performance, per subject 
 FEV1 FEV1/FVC MEFR PEFR Symptom 
|Tk| S FAR S FAR S FAR S FAR S FAR 
0.05 -- -- 0.928 7.01 -- -- -- -- -- -- 
0.1 0.958 6.77 0.876 6.14 0.948 7.19 0.931 8.36 0.985 7.06 
0.25 0.918 5.56 0.853 5.05 0.873 5.75 0.928 7.09 0.972 6.24 
0.3 0.901 5.12 0.715 4.19 0.831 5.16 0.921 6.54 0.972 5.91 
0.4 0.865 4.51 0.582 3.66 0.821 4.74 0.911 6.22 0.967 5.85 
0.5 0.854 4.05 0.501 3.12 0.800 4.32 0.911 5.82 0.961 5.67 
0.75 0.705 3.48 0.468 2.71 0.772 3.90 0.878 5.36 0.882 5.14 
1 0.612 2.85 0.365 2.02 0.691 3.50 0.822 4.90 0.840 4.62 
1.5 0.559 2.26 0.277 1.57 0.575 2.41 0.761 3.97 0.757 3.74 
2 0.473 1.89 0.155 1.03 0.512 1.84 0.687 3.38 0.714 3.35 
3 -- -- 0.124 0.69 0.353 1.34 0.545 2.30 0.670 2.71 
3.5 -- -- -- -- -- -- -- -- 0.545 1.89 
pAUC 0.434 0.250 0.379 0.381 0.448 
Notes: S: Sensitivity (%event); FAR: False Alarm Rate(#/subject- year); “--“ not 
evaluated. pAUC(0-1): partial area “under the curve”. 
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In OC performance, symptom achieves higher per event sensitivity at higher 
false alarm rate (FAR) (e.g., sensitivity 94.8%, FAR 5.47 /subject-year); at lower 
FAR, FEV1 achieves higher sensitivity (e.g., sensitivity 80.2%, FAR 3.81 /subject-
year).  Similarly, symptom achieves higher per subject sensitivity at higher false 
alarm rate (FAR) (e.g., sensitivity 96.1%, FAR 5.67/subject-year); at lower FAR, 
FEV1 achieves higher sensitivity (e.g., sensitivity 85.4%, 4.05 /subject-year).  
With this set of data, the OC curves overlap. By constructing a square box 
region confining sensitivity [0.5-1] and false alarm rate [1-6]/subject-year as the 
focus area of interest, the proportion of the partial area under the curve  to the total 
area of the region was defined as pAUC (0-1). The idea of pAUC is well 
documented in the ROC literature [ 140 ]. Two adjacent OC data points are 
connected with a straight line and the area is summed up using a trapezoidal 
formula. In the per event metrics, both FEV1 (pAUC=0.433) and symptom 
(pAUC=0.471) were superior to the remaining variables (max pAUC=0.344); and 
in the per subject metrics, both FEV1 (pAUC=0.434) and symptom (pAUC=0.448) 
were superior to the remaining variables (max pAUC=0.381). 
ROC Approximation 
The OC can be approximately converted to ROC, the conventional metrics for 
binary trials, as previously described. The entire area under the curve (AUC (0-1)) 
of ROC is interpreted as the probability of true positive detection [141, 142].  
Figure 29 shows the ROC curves, which is by definition, per event metrics 
The ROC result is consistent with the OC: Overall ranking per AUC was 
symptom (0.8360), FEV1 (0.8194), MEFR (0.8068), PEFR (0.7955) and FEV1/FVC 
ratio (0.7875). Symptom and FEV1 remain the best two best variables for event 
detection. As the results were from a limited sample of 28 subjects, the probability 
of true positive statistics against a random guess (50% chance) were calculated 
per formulae in [139] and all p-values <0.001. Therefore, all of the AUC estimates 
suggest discriminating power to separate events from non-event status compared 
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to a random guess. In particular, FEV1 observed sensitivity=85.5% at 
specificity=72.1% and symptom observed sensitivity=84.0% at specificity=68.2%. 
These OC curves do not exactly overlap. Symptom achieves higher sensitivity at 
lower specificity than FEV1, e.g., sensitivity 96.1% at specificity 60.9%,  suggesting 
symptom detects more event at the cost of lower sensitivity.  
 
Figure 29. ROC approximation. 
 
82 
 
Table 9. ROC approximation. 
  FEV1 FEV1/FVC MEFR PEFR Symptom 
|Tk| S 1-SPEC S 1-SPEC S 1-SPEC S 1-SPEC S 1-SPEC 
0.05 -- -- 0.928 0.453 -- -- -- -- -- -- 
0.1 0.958 0.466 0.876 0.393 0.948 0.495 0.931 0.576 0.985 0.486 
0.25 0.918 0.383 0.853 0.246 0.873 0.396 0.928 0.489 0.972 0.430 
0.3 0.901 0.353 0.715 0.214 0.831 0.356 0.921 0.451 0.972 0.407 
0.4 0.865 0.311 0.582 0.181 0.821 0.327 0.911 0.429 0.967 0.403 
0.5 0.854 0.279 0.501 0.150 0.800 0.298 0.911 0.401 0.961 0.391 
0.75 0.705 0.240 0.468 0.107 0.772 0.269 0.878 0.369 0.882 0.354 
1 0.612 0.196 0.365 0.079 0.691 0.241 0.822 0.338 0.840 0.318 
1.5 0.559 0.156 0.277 0.054 0.575 0.166 0.761 0.274 0.757 0.258 
2 0.473 0.130 0.155 0.032 0.512 0.127 0.687 0.233 0.714 0.231 
3 -- -- 0.124 0.013 0.353 0.092 0.545 0.158 0.670 0.187 
3.5  --  -- -- -- -- -- -- -- 0.545 0.130 
Total 
AUC 0.8194 0.7875 0.8068 0.7955 0.8360 
 
 Timing of Detection 
Early warning time is measured by timing of detection, τ. τ is estimated by the 
time when threshold was first crossed as the earliest possible detection time and 
not truncated by the fixed window size of 3 weeks. The summary statistics of τ 
were computed for FEV1 and symptom as below. 
Table 10. Timing of detection τ estimate (days) in the learning set 
Variable Mean±SD Median Range Threshold Events Evaluated 
|Tk| N 
FEV1 10.8±9.6 12.6 45 ~ –13*  0.5 81  
Symptom 10.0±13.5 10.2 48 ~ –31*   1 75  
Note: *τ < 0 indicated a delayed detection compared to the corresponding event 
record.  
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On average, timing of early detection by FEV1 and symptom was 10.8 and 10.0 
days, respectively. FEV1 typically leads symptom in detection timing. The mode of 
detection was at τ=0, coinciding with timing of the corresponding event records. 
483624120-12-24
FEV1
Symptom
tau (days)
 
Figure 30. The distribution of timing of detection τ (days). 
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Performance Evaluation – Results from the Validation Set 
The same detection methods and threshold levels evaluated on the learning 
set were applied in the validation set. OC for the validation set is shown as follows. 
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Figure 31. The Operating Characteristics of individual variables per event. 
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OC per subject
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Figure 32. The Operating Characteristics of individual variables per subject. 
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Table 11. OC performance, per event 
 FEV1 FEV1/FVC MEFR PEFR Symptom |Tk| S FAR S FAR S FAR S FAR S FAR 
0.05 -- -- 0.901 5.49 -- -- -- -- -- -- 
0.1 0.914 7.32 0.886 4.57 -- -- 0.945 7.32 1.000 8.44 
0.25 0.886 5.15 0.623 2.51 0.971 6.07 0.943 6.73 1.000 7.02 
0.3 0.886 4.32 0.514 2.00 -- -- 0.857 6.15 1.000 6.47 
0.4 0.886 3.58 0.371 1.50 -- -- 0.771 5.07 0.950 5.76 
0.5 0.857 2.83 0.320 0.91 0.857 4.82 0.714 4.32 0.925 5.21 
0.75 0.629 2.33 -- -- 0.710 4.14 0.629 3.66 0.875 5.03 
1 0.486 1.75 -- -- 0.600 3.49 0.513 2.78 0.825 4.42 
1.5 0.343 1.00 -- -- 0.543 2.66 -- -- 0.775 4.18 
2 0.200 0.83 -- -- 0.470 2.14 -- -- 0.750 3.71 
3 0.086 0.33 -- -- -- -- -- -- 0.625 2.84 
3.5 -- -- -- -- -- -- -- -- 0.575 2.33 
pAUC 0.547 0.445 0.333 0.257 0.424 
Notes: S: Sensitivity (%event); FAR: False Alarm Rate (#/subject-year); “--“ some 
previous threshold levels were not evaluated as they fell away from the pAUC. 
pAUC: partial area “under the curve”.  
 
Table 12. OC performance, per subject 
 FEV1 FEV1/FVC MEFR PEFR Symptom 
Tk S FAR S FAR S FAR S FAR S FAR 
0.05 -- - 0.945 5.57 -- -- -- -- -- -- 
0.1 0.951 8.19 0.921 4.70 -- -- 0.965 8.19 1.000 8.27 
0.25 0.938 5.70 0.617 2.54 0.985 6.76 0.962 6.84 1.000 6.56 
0.3 0.938 4.93 0.499 2.07 -- -- 0.925 6.33 1.000 6.05 
0.4 0.938 3.90 0.378 1.38 -- -- 0.777 5.36 0.972 5.39 
0.5 0.925 3.01 0.347 0.91 0.921 5.29 0.732 4.55 0.962 4.82 
0.75 0.728 2.38 -- -- 0.780 4.21 0.690 3.81 0.902 4.54 
1 0.516 1.78 -- -- 0.711 3.87 0.551 3.01 0.892 4.13 
1.5 0.460 1.02 -- -- 0.605 2.97 -- -- 0.856 3.94 
2 0.331 0.87 -- -- 0.51 2.25 -- -- 0.785 3.46 
3 0.167 0.33 -- -- -- -- -- -- 0.713 2.67 
3.5 -- -- -- -- -- -- -- -- 0.671 2.43 
pAUC 0.629 0.468 0.384 0.270 0.549 
Notes: S: Sensitivity (%event); FAR: False Alarm Rate (#/subject-year); “--“ not 
evaluated. pAUC: partial area “under the curve”.   
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In OC performance, the highest per event sensitivity was achieved by symptom 
(e.g., Sensitivity 95.0%, FAR 5.75 /subject-year); at fixed FAR, the highest 
sensitivity was by FEV1 (e.g., Sensitivity 85.7%, FAR 2.83 /subject-year).  pAUC of 
FEV1 and symptom was 0.547 and 0.424, respectively. 
Per subject, the highest sensitivity was achieved by symptom (e.g., Sensitivity 
97.2%, FAR 5.39/subject-year); at fixed FAR, the highest sensitivity was by FEV1 
(e.g., Sensitivity 92.5% , 3.01 /subject-year). pAUC of FEV1 and symptom was 
0.629 and 0.549, respectively. 
The OC results from the validation set are generally consistent with the 
learning set, suggesting the detection method, designed based on the learning set, 
can be successfully implemented with new, previously unseen data. It confirms 
that FEV1 and symptom show consistent performance and are the preferred 
variables for event detection. 
ROC Approximation 
Figure 33 shows the ROC curves. 
The ROC result is consistent to the OC: Overall ranking per total AUC was 
FEV1 (0.8279), symptom (0.8180),  FEV1/FVC ratio (0.8130), MEFR (0.8035), and 
PEFR (0.7695). The probability of true positive statistics against a random guess 
(50% chance) per formulae in [139] calculated all p-values <0.001. Therefore, all of 
the AUC estimates suggest discriminating power to separate events from non-
event status compared to a random guess. In particular, FEV1 observed 
sensitivity=85.7% at specificity=80.5% and symptom observed sensitivity=82.5% 
at specificity=69.5%.  
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Figure 33. ROC approximation. 
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Table 13. ROC approximation. 
  FEV1 FEV1/FVC MEFR PEFR Symptom 
|Tk| S 1-SPEC S 1-SPEC S 1-SPEC S 1-SPEC S 1-SPEC 
0.05 -- -- 0.901 0.378 -- -- -- -- -- -- 
0.1 0.914 0.504 0.886 0.355 -- -- 0.945 0.504 1 0.582 
0.25 0.886 0.355 0.623 0.252 0.971 0.418 0.943 0.464 1 0.484 
0.3 0.886 0.298 0.514 0.215 -- -- 0.857 0.424 1 0.446 
0.4 0.886 0.247 0.371 0.187 -- -- 0.771 0.349 0.950 0.397 
0.5 0.857 0.195 0.320 0.139 0.857 0.332 0.714 0.298 0.925 0.359 
0.75 0.629 0.161 -- -- 0.710 0.285 0.629 0.252 0.875 0.347 
1 0.486 0.121 -- -- 0.600 0.24 0.513 0.192 0.825 0.305 
1.5 0.343 0.069 -- -- 0.543 0.183 -- -- 0.775 0.288 
2 0.200 0.057 -- -- 0.470 0.147 -- -- 0.750 0.256 
3 0.086 0.023 -- -- -- -- -- -- 0.625 0.196 
3.5 -- -- -- -- -- -- -- -- 0.575 0.161 
Total 
AUC 0.8279 0.8130 0.8035 0.7695 0.8180 
 
Timing of detection 
On average, the timing of early detection by FEV1 and Symptom was 7.7 and 
6.6 days, respectively, summarized Table 14 in and depicted in Figure 34. 
Table 14. Timing of detection τ Estimate (days), validation set 
Input 
Variable 
Mean±SD Median Range Threshold Events Evaluated 
|Tk| N 
FEV1 7.7±6.6 9.0 29~–18* 0.5 31 
Symptom 6.6±6.7 4.8 26~ – 8* 1 25 
Note: * τ < 0 indicated a delayed detection compared to the corresponding event 
record.  
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Figure 34. The distribution of timing of detection τ (days), validation set. 
Summary 
Wavelet-based multiresolution signal crossover and its directional one-sided 
CUSUM is feasible to detect spirometry decline or symptom increase associated 
with acute pulmonary events. These methods are data driven and can execute 
automatically. Symptom and FEV1 achieved top tier overall per pAUC in OC 
metrics or AUC in ROC metrics, in both the learning and validation datasets. The 
results from the validation set are in general, consistent with results in the learning 
set, suggesting the detection method, designed based on the learning set, can be 
implemented on new, previously unseen data. 
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C h a p t e r  V   
DEMPSTER-SHAFER CLASSFIFIER COMBINATION FOR EVENT 
DETECTION  
Classifier Combination Approaches 
Classifier combination aims to achieve a higher level performance than that of 
each individual classifier. Combining classifiers may improve efficiency and 
reliability in classification. This is because the sets of data misclassified by the 
different individual classifiers would not necessarily overlap. In LTHMP, post 
transplant rejections or infections can originate from different etiologies such as 
small bronchial airways, mid airways or large airways and may be manifest with 
symptoms, thus FEV1, MEFR, PEFR, FEV1/FVC ratio and symptoms may 
potentially offer complementary information, which if combined in an effective way, 
could improve the performance not possible with each individual classifier. 
Therefore, this stage extends from a single-input-based event classification into a 
combination-based event classification.  
Classifier combination has been an active topic in the pattern recognition 
community. Majority voting, neural network, Bayesian and the Dempster-Shafer 
schemes have been proposed with demonstrated successes [143 , 144 , 145 , 
146,147].  The common fixed-rule approaches include majority voting  for binary 
label outputs, and maximum, minimum, median and average/linear combination for 
continuous measurement outputs.  
In particular, Bayesian formalism is a probabilistic model-based approach 
which is now canonical in probabilistic modeling.  However, there are situations 
where the classical Bayesian method is difficult to apply such as lack of proven 
probability distribution model or unavailability of accurate mathematical analysis 
[148]. Because of the challenges in modeling classifier output for time series 
signals, this research looks into rules based on the Dempster-Shafer theory. 
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Dempster-Shafer’s Theory of Evidence 
Dempster-Shafer theory of evidence (DST) is a tool for representing and 
combining measures of evidence. DST is founded on the work of Dempster (1968) 
[149] and Shafer (1976) [150]. According to Shafer and Pearl [151], DST “provides 
a non-Bayesian way of using mathematical probability to quantify subjective 
judgment. Whereas a Bayesian assesses probabilities directly for the answer to a 
question of interest, a belief function assesses probabilities for related questions 
and then considers the implications of these probabilities for the question of 
interest”. DST is a generalization to the Bayesian reasoning with more flexibility 
when the knowledge is incomplete and one has to deal with uncertainty and 
ignorance. DST “have been popularized in the literature on Artificial Intelligence 
(AI) and Expert Systems, with particular emphasis placed on combining evidence 
from different sources” [152]. This is particularly desirable when information from 
two different apparatus, spirometry and symptom is used in LTHMP. Many 
engineering sensor fusion problems resort to DST to reduce high false alarm rate 
[ 153 ]. The output of several classifiers may be combined, yielding decision 
procedures very robust to sensor failures [154]. 
A Mathematical Description of DST 
Let Θ be a set of mutually exhaustive and exclusive atomic (not sub dividable) 
hypotheses where each possible state of a system θ1,…, θN ∋Θ.  Θ is referred as 
the “frame of discernment”. Each hypothesis, θi  is assigned a degree of belief 
called the “basic probability assignment” (bpa), through a set of belief mass 
functions, m(.). A mass function m(.) assigns beliefs in a hypothesis H as “the 
measure of belief that is committed exactly to H (Shafer)”. bpa is subject to the 
following constraints: 
m(ø)=0 for an empty set ø, and  
m(H)≥0, Θ⊆∀H , and  
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Each hypothesis that has m(.)>0 defines a focal element and their associated 
bpa define a body of evidence (BOE). 
A belief function describes the belief in a hypothesis H. 
∑
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for any belief committed to hypothesis B that is part of H. A plausibility function of 
H is defined as  
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and the rule to combine independent evidence E1, E2, corresponding to belief 
committed to hypothesis B and hypothesis C, respectively, into a single belief  
(“⊕ ”), 
m12=m1⊕m2  
is 
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Notes on the Independence Assumption 
DST assumes independence evidence sources, although few applications 
actually required independence [144,145,146] and it was not considered a major 
concern [155]. Here, we briefly discuss and justify this independence assumption.  
By definition (Figure 3), PEFR and MEFR are flow rates measured at 
independent sequential time points; FEV1, FVC are both volume measures with 
FEV1 being a fixed-time volume and FVC the total capacity volume is unrelated to 
time measures. Therefore, these variables are independent measures of different 
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aspects of a physical maneuver. Their derivatives are reasonably assumed 
independent as well.  
Symptom is measured by a different apparatus from spirometer, which is the 
subject him/her- self. Based on these considerations, the independence 
assumption for the Dempster-Shafer rule is reasonably satisfied. 
Design of A Dempster-Shafer Classifier  
At this point, a single input vector x ∈ R1 has been processed into a CUSUM 
vector v ∈R1, where v[ti]  = f(x[ti]), at time ti, i=1,2,3,...,n, and  assume vj are soft 
labels (as opposed to “hard” labels such as binary classification) of the jth segment 
of ti as a continuous measurement of support to event. The classifier output v can 
reach a binary classification by comparing v to a threshold. 
To apply Dempster-Shafer theory to event detection, this research followed the 
frame work for signal detection by Safranek [156], Boston [157] and Jones [158].  
The event detection problem was reduced to just two elements: event present 
(S) and event absent (N) at any time instant. All possible subset of the set {N, S}, or 
the power set contains four elements: {N}, {S}, and two additional elements, {N or 
S} denoted as {U}, the union of N and S, i.e., either event present or noise, and the 
empty set {ø}. This set Θ={N, S, U, ø} is the “frame of discernment”. 
Let us select an event detector such as a spirometry variable, x, which 
contributes its observation by assigning its beliefs over Θ as bpa, denoted by a 
mass function mi. A bpa m(A) represents the portion of total belief that is assigned 
exactly to set A. bpa is subject to the following constraints: 
mx(ø)=0    
mx(S) + mx(N) + mx(U)=1   
mx(U) represents ignorance concerning presence or absence of an event signal.  
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To combine evidence from both x and y that supports a proposition of interest 
S, the combination of x's observation mx and y's observation my in DST is 
∑
∑
≠∩
=∩=⊕
φCB
yx
SCB
yx
yx CmBm
CmBm
Smm )()(
)()(
))((
                                                                  (15) 
Next, the problem concerns combining multiple output-level classifiers 
previously derived. A multi-classifier combination involves these major steps: 
1) Select a confidence factor conversion/normalization; 
2) Assign mass function to obtain belief and ignorance levels; 
3) Calculate combined belief per the Dempster-Shafer Rule; 
4) Classification. 
 
 
 
Figure 35. The converter function cf(v) and bpa assignment procedure.  
(a) conversion of input discriminator variable, v, into confidence factor using a 
sigmoid function; (b) bpa mass functions. 
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Converter Function  
The CUSUM, previously derived output in the wavelet approach for a single 
variable, is used as the input to the combination rules. The first stage of the 
procedure was to convert the one-sided CUSUM vector v to a confidence factor 
cf(v), on a scale of 0-1, which represents a level of confidence in (or not in) the 
variable’s support to an event hypothesis. A sigmoid function was proposed by 
Safranek [156]  
)(1
1)(
θ−−+
=
vke
vcf                                                                                               (16) 
where k describes the steepness of the curve and θ  produces a neutral support. 
Given a hypothesis, S, and its compliment, N, a larger v value implies a larger cf(v) 
which provides more support to S, while a small v provides more support to N, and 
vice versa. Let 
)()( 1
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which normalizes an input vector v to cf(v) ∈ [0,1] and control parameters (k,θ) or 
(a,b). At a threshold cutoff T, the converted cutoff value z is  
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Continuing from equations (8-9), for the jth CUSUM sequence vj, j=1,2,…, J, 
select a set of parameters (a,b) such that OC(v|T) ≡ OC(cf(v)|z,a,b). This is to 
compute a, b such that the mean squared error (MSE) function is minimized, i.e., 
(a,b) = arg min MSE { |OC(vj|T) − OC(cf(vj)|z,a,b)|}                                          (18) 
for all J CUSUM sequences. This was done by iteratively updating (a,b) such that 
equation (18) convergences.  
97 
 
Figure 36. Iterative solution for the converter function cf(v). 
One set of solution of (k,θ) for the confidence converter function was computed 
as follows.  
Table 15. A set of parameters for the converter function 
|CUSUM| as Input Variables 
 
θ  k  
FEV1 0.402  2.49  
FEV1/FVC ratio 0.387 2.58 
PEFR 0.380 2.63 
MEFR 0.388 2.58 
Symptom 0.403 2.48 
1. Define a grid of (ai,bi), i=1, 2, … I. 
 
2. Select Tk , classify cf(vj) at a threshold zk=cf(Tk), k=1,2,…,K. 
 
3. For the jth cf(vj), compute jpˆ  =max(cf(vj)), j=1,2, …, J. (page 65) 
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Compute xk=SENS(zk), yk=FAR(zk) for all J per Eq’s set (8-9) (page 65) 
Compute MSE { |OC(v|T) − OC(cf(v)|zk,a,b)|} as 
kyyxx
k
kkkk /)()( 210210∑ −+−  
Subscript “0“denotes OC(|T) in CUSUM scale, “1“ denotes OC(|zk,a,b) in cf(v) 
scale. 
 
4. Update a new set of (ai,bi), repeat Step 2-3. 
5. Select (ai,bi) such that arg min MSE { |OC(v|T) − OC(cf(vj)|z,a,b)|}.                                           
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bpa (Basic Probability Assignment) 
Assume a classifier v to differentiate event class membership. We are 
concerned about combining output information based on the continuous 
measurement level. Without losing generality, assume the increase of v 
corresponds to an increased support for event, and vice versa.  
The bpa mass function per Safranek is a simple piecewise linear function.  Per 
Figure 35 (b), the belief assignments bpa is: 
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The combination (“⊕”) of two independent BOEs mx(.) and my(.) are as follows: 
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In theory, DST combination rule is associative and more classifiers can be 
combined recursively, m(s) = (m1(s) ⊕ m2(s))… ⊕ mk(s), k∈ Z. 
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The bpa functions are related to the decision maker’s belief and trust of the 
input variable. Given a lower confidence of uncertainty, Ql, and an upper 
confidence of uncertainty, Qu, if Ql = Qu = 0 indicates no uncertainty assigned by 
the user. Larger Q indicates higher level of uncertainty. Per Safrankek and Jones, 
an uncertainty confidence interval (Q) [0.4 - 0.9] implies fairly good amount of 
ignorance inherited in the input variable for belief assignment. Given Ql and Qu, 
and A, B can be assigned as follows:  
l
lu
lu
Q1B
2QQ1
QQA
−=
−+
−
=
                                                                                             (21) 
Table 16. bpa parameter table 
Ql Qu A B 
0 0 0 1 
0.1 0.2 0.1 0.9 
0.2 0.3 0.1111 0.8 
0.3 0.4 0.7 0.125 
0.4 0.9 0.4545 0.6 
Note: Parameters in use bold-faced. 
The selection of uncertainty levels is left to user’s discretion as it is by 
definition, subjective. Due to the linearity of m(.), sets of similar (Ql, Qu) would 
produce similar classifications as they only modify the magnitude of bpa which is 
offset by adjusting the threshold cutoff T’. A set of low uncertainty (Ql,Qu)=(0.1,0.2) 
corresponding to (A,B)=(0.1, 0.9) was used in this study.  
Illustrations 
As illustrated (Figure 37), bpa mass function m(s) (belief) resembles the one-
sided CUSUM sequences (rectified to be positive). The bpa’s, show “disbelief” 
through most part of the monitoring. This is intuitive and consistent with that events 
occur at discrete times.  
100 
0 50 100 150 200 250 300 350
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Monitoring Days
BO
E 
FE
V1 Belief event present
Belief event absent
Ignorance
 
 Figure 37. Illustrated bpa of FEV1. 
Vertical axis is the bpa’s; Horizontal axis is the monitoring days.  
The lines represent belief of event ( “—“), belief of no event( “—“), and ignorance ( 
“—“) as labeled in the plot; the vertical lines indicate events ( “—”). 
DS combinations of two individual inputs are first illustrated. The focus is to 
combine symptom and spirometry. 
In Figure 38 (A and B), the input waveforms are the event belief bpa series from 
FEV1 (mx(s)) and symptom (my(s)), respectively. Figure 38 illustrates that event 
labeled 1 was detectable by FEV1 but missed by symptom. One also notices that 
waveform sequences from the two inputs do not necessarily align in time and their 
combination is no longer monotonic and may result in truncated waveforms. When 
both waveforms align, the combination mx,y(s) retains the amplitude of both 
waveforms. When both the waveforms are small, they do not combine into large 
b
p
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waveforms and are noises to be eliminated. DS combination, per its operation 
behavior (illustrated in Appendix B), tends to reduce small waveforms and retain 
larger waveforms. In this case, all events are visually identifiable based on the 
combined waveforms. In particular, the event misclassified by symptom (labeled 
1) is detected by the combination, highlighting the basic benefit when independent 
detection errors are made by the two classifiers. There are increasing levels of 
complexity in classification with the sometimes truncated waveforms as a result of 
combination. 
 
Figure 38. Illustration: DS combination of FEV1 and symptom. 
Horizontal axis is the day of monitoring.  
A. bpa mx(s) of FEV1.  
B. bpa my(s) of symptom. 
C. DS combination. Vertical lines indicate events.  
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In Figure 39, DS rules using two sets of parameters (A,B), denoted as DS1 and 
DS2, and an average rule are illustrated. DS1 retains the waveforms better than 
DS2 which is somewhat similar to the average rule. DS1 was used for OC 
performance evaluations in this research.  
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Figure 39. Illustration: Combining FEV1 and Symptom by DS1 (A=.1, B=.9), DS2 
(A=.4545, B=.6), and Average  
Horizontal axis is the day of monitoring. Horizontal lines are grid lines. 
Vertical lines indicate events.  
A 3-week window is plotted as brackets below the horizontal line. 
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Figure 40. Summary of the Dempster-Shafer combination for detection 
Summary of the Dempster-Shafer Combination 
 
1. Obtain two single classifier time series output vectors v=v(ti), i=1,2,3,...,n, 
denoted as x and y, respectively, based on previously described procedure in 
Chapter V. 
2. Calculate bpa (basic probability assignment)  
a. Normalize v into [0,1] per )(1
1)(
θ−−+
=
vke
vcf (Figure 36)  
b. Perform bpa as 
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 (Figure 35-b and Eq(19)) 
where m(S)=belief of event, m(N)= no belief of event, m(U)= ignorance,   
)(SmI , )( NmI and )(UmI are indicator functions, and A,B are scalars for m(.) 
3. Apply Dempster-Shafer rule below to the two bpa vectors )(Smx  and 
)(Sm y where at each time point ti, the combined belief  is 
))()()()((1
)()()()()()())((
NmSmSmNm
SmUmSmUmSmSm
Smm
yxyx
xyyxyx
yx +−
++
=⊕  (Eq (20)) 
4. Obtain an output vector ))()(( iyx tSmm ⊕ , i=1,2,…,n for classification(page 63) 
(MATLAB code in Appendix D) 
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Results 
      Detection performance per DS combination was evaluated on both the 
learning set and the validation set as follows.  
OC of DS Combination 
DS combinations of two single classifier inputs which include at least one of 
FEV1 and symptom (single best variables), are depicted in the following figures.  
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Figure 41. Operating Characteristics of DS combination, per event, learning set.  
Data table in Appendix C. 
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Figure 42. Operating Characteristics of DS combination, per subject, learning set.         
Data table in Appendix C. 
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Similar to the learning set, the OC estimation for the validation set is illustrated 
below.  
OC per event
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Figure 43. Operating Characteristics of DS combination, per event, validation set.      
Data table in Appendix C. 
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OC per subject
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Figure 44. Operating Characteristics of DS combination, per subject, validation 
set.  
Data table in Appendix C. 
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Per pAUC calculated according to the confining region (Sensitivity: [0.5-1], 
FAR: [1-6]/subject-yr)  and summarized in the table below, two variable Dempster-
Shafer (DS) combination candidates are compared. 
Table 17. pAUC of individual and DS Combinations 
  
DS Classifier’s pAUC* 
 
Data Set  FEV1 & Symptom 
FEV1 & 
MEFR 
MEFR & 
Symptom  
 
FEV1 & 
FEV1 /FVC 
 
The Learning Set Per Event 0.545 0.462 0.471 0.438 
 Per Subject 0.524 0.463 0.444 0.442 
The Validation Set Per Event 0.634    0.439    0.497    0.358 
 Per Subject 0.628 0.503 0.450 0.410 
*pAUC – Proportion of partial Area Under the Curve which confines region:  
 Sensitivity [0.5-1] and False Alarm Rate [1-6]/subject-year 
 
Not surprisingly, combination of the two best single classifiers, FEV1 and 
symptom, produced the best results in OC and in pAUC. These results also 
suggest combination involving weaker spirometry variables brings no advantage to 
further performance improvement.  
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Results Compared to the Single Input Classifiers 
Next, OC curves from the single classifiers of FEV1 and symptom and their DS 
combination are compared. Performance metrics previously cited are highlighted 
with a square box. 
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Figure 45. Comparing DS combination vs. single variables, learning set. 
Data table in Appendix C.  
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Figure 46. Comparing DS combination vs. single variables, validation set. 
Data table in Appendix C. 
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The OC curve of DS combination is visually above that of the single classifiers. 
The OC improves by covering more pAUC. For example, OC of (Sensitivity, FAR 
[/subject-year]) per event were: FEV1(81.2%, 4.29), Symptom(82.3%, 4.26), and 
DS(84.1%, 3.73) in the learning set; and FEV1(85.7%, 2.83), Symptom(87.5%, 
5.03), and DS(87.7%, 2.86) in the validation set. The false alarm rates reduced at 
similar sensitivity. From Table 18, pAUC of DS improved over FEV1 ranging from 0 
- 25%, and improved over symptom ranging from 14 - 49%.  
Table 18. pAUC of individual variables and DS Combinations 
Data Set  FEV1 Symptom DS (FEV1 & Symptom) 
The Learning Set Per Event 0.433 0.471 0.545 
 Per Subject 0.434 0.448 0.524 
The Validation Set Per Event 0.547 0.424 0.634    
 Per Subject 0.629 0.549 0.628 
*Partial Area Under the Curve region:  
 Sensitivity [0.5-1] and False Alarm Rate [1-6]/subject-year 
 
Based on these results, DS resulted in an incremental improvement of pAUC 
over the best individual classifiers.  
Summary 
The combination of classifiers reduces misclassification errors by individual 
classifiers from two different apparatus of spirometry and symptom. Dempster-
Shafer (DS) combination of FEV1 and symptom, two best single variable 
classifiers, provides higher degree of performance than either variable alone, 
namely, there is increased sensitivity at the same false alarm rate. Per OC metrics, 
the results are generally consistent between the learning set and the validation set. 
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C h a p t e r  V I   
DISCUSSION  
In the following, the clinical relevance of this research is discussed first as it is 
the far most important followed by a review of methodology and factors affecting 
performance of the algorithm.  
Clinical Relevance  
Compared to the previous automated triage [17] which assessed the potential 
of a clinical problem, this research steps further and has evaluated the detection of 
actual clinical events, based on the same home monitored spirometry and 
symptoms data. This was realized by customizing methods that fully utilize 
information embedded in the data, extracting pertinent features, and being guided 
by knowledge of the occurrence of true clinical events.  
The CUSUM classifier performs event detection sequentially. This sequential 
detection is a significant departure from a fixed sample trial-based detection, which 
is subject to inflation of false positives with frequent testings (denoted as “multiple 
testing or multiplicity” problem [159]).  
The results show that the best performance was achieved with FEV1 and 
symptoms in both datasets. For example of FEV1, in OC per subject, sensitivity 
was 85.4% at 4.05 false alarms per subject-year in the learning set and 92.5% at 
3.01 false alarms per subject-year in the validation set. The corresponding 
threshold in OC or ROC point would be set at 0.5 [liter-day] for FEV1. Sensitivity 
would increase with higher rate of false alarms at lower thresholds: for example, 
sensitivity would be 91.8% at 5.56 false alarms in the learning set and 93.8% at 
5.70 false alarms per subject-year in the validation set. The thresholds can also be 
adjusted at user’s discretion to balance preferred sensitivity and tolerance of false 
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alarms. In addition, these detections were associated with early warning times 
comparing to the corresponding event records.  
In this study, both the learning set and the validation set are from clinical 
setting, and event detection performance was evaluated on the entire data series 
of each individual subject which gives a complete assessment of detection 
performance. Therefore, the event detection results are clinically relevant.  
These performance results exceeded reports from clinician-supervised post 
lung transplant monitoring studies by Morlion et al who reported a sensitivity of 
63% [18] and Wagner et al who reported a sensitivity of 80% with low (but 
unspecified) specificity [14] both of which were based on daily surveillance of FEV1 
and FEF25-75%(MEFR). In related fields such as colon cancer screening studies, it 
is also generally considered clinically meaningful to have a sensitivity at or above 
this range (60% plus) [160]. Therefore, the event detection results are clinically 
meaningful. 
The best overall detection performances were found through FEV1 and 
symptoms, however, this interpretation should be confined within the context of 
acute bronchopulmonary event detection, the targeted event type in this research. 
It does not deny the importance of other variables, such as the mid flow rate 
(MEFR), which is considered an early indicator to chronic rejection (i.e., 
Bronchiolitis Obliterans) [161] and is not a targeted event type in this research.  
The use of home monitoring and detection may not preclude a visit to clinic for 
formal examination and diagnoses. However, more than 80% events would be 
detected at potentially sooner time. It is also worth noting that healthcare and 
patient management as sophisticated and costly as they are today, such as 
detection performance can be achieved by a potentially low cost noninvasive 
computerized analysis of home spirometry /symptom alone.  
It is well known that spirometry alone does not recognize the etiology of 
pulmonary dysfunction [2,162]. A back pain or a newly diagnosed cancer and 
treatment observed in our cases may fully explain the worsening of patient’s 
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spirometry and symptom. But distinction between non-pulmonary events and the 
pulmonary events is not always possible due to the available details in the event 
annotation. Therefore, this study accounted those otherwise clinically important 
incidences for “false” alarms due to the strict definition of event. In other words, the 
true clinically false alarm rate would be lower than estimated.  
Factors affecting event detection performance  
Any event detection research method would be affected and limited in 
performance if it encounters critically missing data, especially incomplete or 
incorrect outcome (event) classifications. 
Incomplete Monitoring Data  
It has been reported non-adherence to home spirometry was connected to 
occurrence of events and graft survival [163,164]. In the study datasets, some 
events might have hindered the subjects from performing home test and 
consequently, these critical data values were not available. There were learned 
cases that subjects were reluctant to perform home testings when they expected 
the results to be poor and were discouraged by that.  On the other hand, data 
missing could be due to “excusable” scenarios such as being recently injured from 
falling and were not physically feasible to perform home testing; or subjects could 
have been seen recently at the clinic whose conditions were deemed acceptable; 
or subjects could have been on vacation which the clinical care staff was made 
aware of. Therefore, if data are not reported regularly, one first need to rule out 
that subject’s failure of data transmission is not due to event related decline in 
health. 
 
 
115 
Incomplete Event Records 
Event record omissions can present a significant problem to rule training, since 
one basic assumption on training is to have complete and non-contradictory data.  
Initially, researchers sourced the learning set events from the medical records 
at FUMC.  Based on initial assessments of functional measurements and symptom 
diaries, researchers closely scrutinized other FUMC records, looking for any 
indication of an event.  It was estimated that as high as 40 percent of all events 
might not have been ascertained from the medical record alone [95].  They 
surmised that FUMC record omissions occurred when patients sought medical 
attention outside of the Transplant Center for their events.  Omissions could then 
occur because the local doctors failed to communicate event details back to the 
Transplant Center and / or the Nurse Coordinators at the Transplant Center may 
have written easily missed cursory notes in the charts following event-informative 
telephone calls. 
The potential impact of missing event records was acknowledged at method 
selection stage. The method used to derive event features does not require explicit 
output status at every time instant, and is free from assuming an underlying input-
output relation model. In the case of a missed event record, most likely one true 
positive would have been denied and instead counted as a “false positive”. 
However, this would penalize the overall false alarm rate proportionally to all 
candidate variables. Thus performance comparison is not likely to be affected by a 
few missed events. For example, as in the learning set, assume an additional 20 
percent of events were not reported then roughly 40 events would not be included 
in the 101 events. With 80% sensitivity, 32 events would have been counted as 
false alarms. That would correspond to 0.86 (32/37.3)/subject-year lower false 
alarm rate.  
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C h a p t e r  V I I   
CONCLUSION AND FUTURE WORK 
Summary of Contributions 
The analysis of post lung transplant home monitoring data is an underserved 
research area according to the paucity of related publications in the recent years. 
One key remaining challenge, the detection of actual clinical events, has been 
addressed in this dissertation research. This research overcomes the limitations in 
the conventional approaches and exploits numerous cross-discipline 
methodologies. The wavelet multi-resolution signal analysis, crossover CUSUM for 
sequential detection, and Dempster-Shafer combination of existing classifiers, 
each represents the first attempt in this domain literature.  
 
The primary contributions of this dissertation research are: 
 
1. This research represents the first study to carefully characterize long term 
home monitored data series in LTHMP. Data were demonstrated to be 
nonlinear, nonstationary, dynamically evolving with long range dependence 
and contain no known signature patterns readily indicative of events.  
2. In this research, a wavelet-based approach was used to analyze time 
dependent scaling behaviors in data, to re-estimate the underlying signal, 
and to extract event discriminating features. This data-driven approach is 
free of any underlying modeling and is applicable to individual level 
dynamical data.   
3. By applying a directional cumulative sum (CUSUM) of multiresolution signal 
crossover, the event detection scheme has become a sequential testing of 
change. Sequential detection is advantageous since it may allow for earlier 
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detection than is possible using trial-based testing with fixed window size. 
The CUSUM has been demonstrated as an accurate and reliable event 
indicator. Events can be classified at clinically meaningful sensitivity and 
specificity, with potential gain of early detection. 
4. Dempster-Shafer (DS) multiclassifier combination further reduces the data 
dimensions and achieves higher sensitivity at fixed false alarm rate than with 
a single classifier. More importantly, DS provides a unified approach to 
combine results from different sources or different architectures. Therefore, 
this is a two stage classification approach extending from univariate 
classifiers to the combination. 
5. The event detection methods, devised under a learning set, demonstrated 
reproducible results in the validation set. Because both the data sets reflect 
the clinical setting, the performance results are clinically meaningful. It is 
recommended to use FEV1 and symptom for event detection, or their 
combination for enhanced detection. Because the computation load is 
manageable under the event detection framework, it has the potential to 
perform computations in real time.  
 
In conclusion, this dissertation research investigated a set of methods for the 
detection of true clinical events based on data from clinical settings, and 
demonstrated promising and clinically meaningful results. The event detection 
methods are ready to put into practical use. 
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Future Work 
Potential Research. The appropriate data sets containing accurate event 
information are extremely precious to this research while no public data are 
available. With more collection of representative and quality data, more stable and 
representative results based on the same methodology detailed in this research 
can be expected. 
As the healthcare is trending towards personalized analysis [165], the alarm 
cutoff threshold may be set as adaptive and/ or personalized through a learning 
process. Machine learning methods including Bayesian modeling can potentially 
be set up and updated according to learning. This could maximize sensitivity/ 
minimize false alarm rate at the subject level.  
For the classifier combination approach, there are many possibilities: The 
control parameters in the Dempster-Shafer combination may also be set up as 
learning parameters, and be personalized to optimize event detection. Other 
competing combination schemes, such as weighted linear sum [166], averaged 
Bayes Classifier, or other variations of the Dempster-Shafer combination can be 
attempted. With large datasets, one can leverage simulation oriented approaches 
such as bagging and boosting algorithms [167,168] which have been reported with 
successes to combine weak classifiers [169].  
Implementation. To make a real impact, the methodologies from this research 
need to be implemented in LTHMP. The next step is to test the methods in a 
prospective clinical setting over a period of time. Computation efficiency, ease of 
use, real time data screening and cleaning, user interface, and so on, become 
equally important as the methods themselves.  
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APPENDICES 
Appendix A. Definitions used in charactering time series data 
Sliding window 
A rectangular sliding window is used to summarize the data dynamics over 
time. An overlapping sliding window of size n intercepts fixed data points from a 
sample sequence and moves by a block size of nx data points at a time.  
Moving Average  
A simple moving average is computed by taking the average of all data points 
contained in a rectangular sliding window with a refreshing rate of n. 
The Automated Triage Algorithm essentially employs such a moving average 
estimate. A moving average or “rolling average” is one of a family of similar 
techniques used to analyze time series data. Moving averages are used to smooth 
out short-term fluctuations, thus highlighting longer-term trends or cycles. These 
averages are similar to the low-pass filters used in signal processing. The basic 
assumption is linearity and Gaussian white noise. 
Variance 
The variance is  
A moving variance computes the variance of data series contained in the 
sliding window involving n observations. 
∑
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Autocorrelation at lag τ 
The autocorrelation is 
Autocorrelation indicates if a monitored variable is random per inspection of 
autocorrelation plots, of which the first moment (mean) and second moment 
(variance) changes throughout the sample sequence.   
Signal Noise Ratio (SNR) 
The signal noise ratio (SNR) is defined as 
SNR ≡ |V
|V|
i
i
− iX
  
where Xi is the data vector, Vi is the denoised data representation, and “| |” denotes 
the norm of the data vector, as in MATLAB.  
The signal noise ratio is calculated using a sliding window at each window 
position. The width of the overlapping sliding window is set at n=20 and a block 
size nx=2. 
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Appendix B.  Demonstration of Event Detection Using the Triage Decision Support 
Algorithm 
 
As illustrated on the next page, the automated triage algorithm was emulated to 
show how it would generate alarms. A simple threshold based algorithm is subject 
to high rate of false alarms. In this example, there were over a total of 200 alarms 
over two years.  
An alarm is issued if the current weekly average FEV1 declines 6% or greater 
from the maximum of the previous 3 week MA or 2 month monthly MA. There were 
23 and 56 alarms prior to the two events, and 151 alarms generated without 
ending in an event. Note although the algorithm is sensitive enough to issue 
alarms prior to the two events, it also produces a large number of false alarms in 
the later period. 
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Figure 47. Illustration of a simple threshold-based event detection and alarm 
generation.  
The rule emulates the triage algorithm on daily basis. FEV1 (Force Expiratory 
Volume (liters) in one second) is the monitoring variable.  
 
Top: Original FEV1 signal recordings and event indicator (red lines).  
 
Bottom: Moving Average (MA) (7 day in blue, 30 day in green) and detection alert 
(yellow lines).  
 
(Subject: X5198) 
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Figure 48. The CUSUM approach derived in this research reduces maximum 
number of false alarms to 13, of which two sequences detect the events. 
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Illustration of Simple Combination Rules  
For combination at decision level, intuitive simple AND/ OR operation is shown 
not a good combination rule as illustrated next.  
Suppose the inputs are FEV1 and symptom. As in Figure 49, their CUSUM 
sequences are plotted and aligned by time. The AND operation would result in 
positive detection when both sequences exceed their locally set threshold values, 
shown as the truncation of the CUSUM sequences. The OR operation would be 
when either of the sequences exceeds its threshold. The resulting combinations 
are pulse-like sequences. These pulses can be classified per event status as 
described in Chapter IV-Classification and Performance Evaluation. 
From this representative illustration, one learned that the AND operation would 
reduce event delectability by completely cancelling out inputs if there is 
disagreement. Indeed, AND operation does not leverage on the compensating 
potentials of the monitoring variables. The OR operation, on the contrary, will 
increase event delectability as well as the false alarm rate. 
Based on the locally set thresholds |T|=0.5 for FEV1 and |T|=1 for symptom, the 
overall performance evaluation of an OR operation of FEV1 and symptom yielded 
a per-event sensitivity of 74% with false alarm rate of 4.6/subject-year, and a per-
subject averaged sensitivity of 78% with false alarm rate of 4.9/subject-year.  
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Figure 49. Simple AND/ OR Combination of FEV1 and symptom  
Horizontal axis is the day of monitoring.  
A: Symptom CUSUM  
B: FEV1 CUSUM  
C: Simple AND (upper) - OR (lower) combination 
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An Experiment Comparing DS Classifier Combination and Other Fixed Rules 
Multiple classifier combination is inspired by the potential of overcoming 
weakness under a univariate approach. It also has practical utility in the case that 
critical observations are missing from one variable but available from another 
variable. Given two input series x and y. The output classifier series are denoted 
mx(s) and my(s) respectively. Since x and y are independent pieces of evidence, the 
Dempster-Shafer rule of combination can be applied as: 
mxy(s) = mx(s) ⊕ my(s) 
Because of the communicative property, the DS combination rule can be 
iteratively applied to include new classifiers. On classifier combination strategies, 
other common schemes are majority vote, min, max, median, average (linear sum) 
and product rules. To illustrate the behavior of a DS rule, two sets of DS rules are 
compared to the average in Figure 50. The data table below also illustrates the 
min, max and product rules.  
Two input sequences X, Y ∈ [0,1] are generated to cover the full range of typical 
values. Two DS rules, i.e., DS1 has no ignorance assigned and DS2 has moderate 
ignorance assigned. The outputs are plotted as mirror images to the average. 
Compared to the average, the DS provides flexible combination behaviors. For 
example, opposing inputs (0.01, 1) gives simple average of 0.5005, vs. DS1 of 
1.00 and DS2 of 0.38; high value inputs (0.998, 0.725) gives simple average of 
0.86, vs. DS1 of 0.999 and DS2 of 0.748; low value inputs (0.326, 0.16) gives 
simple average of 0.24 vs. DS1 of 0.086 and DS2 of 0.033; and low value inputs 
(0.23, 0.11) gives simple average of 0.17 vs. DS1 of 0.036 and DS2 of 0.00. 
Therefore, the average does not eliminate any inputs. DS2 behaves similar to the 
average. DS1 operates asymmetrically and cancels out inputs towards zero when 
both belief values are low; and behaves as an OR/ max operator when at least one 
of the input values is high. DS has the advantage of generating less ambiguous 
combination waveforms by cancelation of small values, as opposed to the average 
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rule. These behaviors are consistent with the design rationale and can reduce 
false alarm rate at fixed sensitivity.  
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Figure 50. DS combination compared to other rules. 
Top: Input sequences X and Y ∈ [0 ,1]. 
Bottom: Average, DS combination (DS 1, A=0.1,B=0.9), and DS combination (DS 
2, A=0.25,B=0.6).  
Input X 0.010 0.305 0.987 0.998 0.990 0.858 0.590 0.418 0.326 0.230 
Input Y 1.000 0.987 0.758 0.725 0.652 0.489 0.306 0.209 0.160 0.111 
Minimum 0.010 0.305 0.758 0.725 0.652 0.489 0.306 0.209 0.160 0.111 
Average 0.505 0.646 0.873 0.861 0.821 0.673 0.448 0.314 0.243 0.170 
Maximum 1.000 0.987 0.987 0.998 0.990 0.858 0.590 0.418 0.326 0.230 
Product 0.010 0.301 0.748 0.724 0.645 0.420 0.181 0.087 0.052 0.026 
DS 1 1.000 0.971 0.996 0.999 0.995 0.853 0.388 0.160 0.084 0.036 
DS 2 0.380 0.504 0.757 0.748 0.710 0.538 0.225 0.081 0.033 0.000 
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Appendix C. Additional Data Tables 
Data tables of Dempster-Shafer combination not listed in main text are included 
in this section.  
Learning set: Figure 41 and Figure 42. 
OC performance, per event 
 
DS 
(FEV1, symptom) 
DS 
(FEV1, MEFR) 
DS 
(MEFR, symptom) 
DS 
(FEV1, FEV1/FVC) 
|Tk| S FAR S FAR S FAR S FAR 
0.025 0.980 6.00 0.952 6.50 0.958 5.66   0.871 5.36 
0.05 0.980 5.42 0.940 6.06 0.948 5.47   0.851 4.83 
0.1 0.887 4.60 0.925 5.63 0.865 4.80 0.812 4.29 
0.15 0.841 3.73 0.861 4.77 0.823 4.26   0.802 3.81 
0.2 0.752 2.99 0.752 3.62 0.757 3.62   0.693 3.11 
0.3 0.680 2.64 0.709 3.02 0.729 3.06 0.624 2.49 
0.4 0.629 2.12 0.605 2.13 0.650 2.55 0.554 1.88 
0.45 0.560 1.79 0.498 1.62 0.555 1.82 0.446 1.56 
0.5 0.508 1.65 0.952 6.50 0.958 5.6
6 
0.871 5.36 
pAUC 0.545 0.462 0.471 0.438 
Note: S: Sensitivity (%event); FAR: False Alarm Rate (#/subject-year).  
OC performance, per subject 
 
DS 
(FEV1, symptom) 
DS 
(FEV1, MEFR) 
DS 
(MEFR, symptom) 
DS 
(FEV1, FEV1/FVC) 
|Tk| S FAR S FAR S FAR S FAR 
0.025 0.990 6.80 0.975 6.96 0.967 5.85 0.936 5.56 
0.05 0.990 6.37 0.972 6.50 0.961 5.67 0.917 5.12 
0.1 0.980 5.61 0.965 5.42 0.892 5.02 0.884 4.50
1 0.15 0.951 5.07 0.844 4.34 0.840 4.62 0.854 4.05 
0.2 0.890 4.00 0.704 3.33 0.757 3.74 0.705 3.48 
0.25 0.766 3.47 0.632 2.81 0.714 3.35 0.612 2.85 
0.3 0.697 2.86 0.589 2.32 0.651 2.71 0.559 2.26 
0.4 0.613 2.32 0.518 1.88 0.538 1.89 0.473 1.89 
0.5 0.553 1.86 0.975 6.96 0.967 5.85 0.936 5.56 
pAUC 0.524 0.463 0.444 0.442 
Note: S: Sensitivity (%event); FAR: False Alarm Rate (#/subject-year). 
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Validation set: Figure 43 and Figure 44. 
OC performance, per event 
 
DS 
(FEV1, symptom) 
DS 
(FEV1, MEFR) 
DS 
(MEFR, symptom) 
DS 
(FEV1, FEV1/FVC) 
|Tk| S FAR S FAR S FAR S FAR 
0.05 1.000
0 
-- 1.0000 -- 1.000 -- 1.000 -- 
0.1 0.927 4.87 1.0000 -- 1.000 -- 1.000
0 
-- 
0.15 0.901  3.50 0.975 7.40 0.950 8.90 0.900 5.90 
0.2 0.877 2.86 0.925 4.90 0.950 6.25 0.700 3.25 
0.25 0.776 2.62 0.900 3.30 0.800     3.95 0.600 2.25 
0.3 0.627 2.33 0.750 2.60 0.450 1.25 0.550 1.80 
0.4 0.551 1.74 0.550 1.50 0.400 0.80 0.250 1.10 
0.5 0.476 1.09 0.200 0.80 0.350     0.50 0.075 1.00 
pAUC 0.634     0.439     0.497     0.358 
Note: S: Sensitivity (%event); FAR: False Alarm Rate (#/subject-year); “-“ not evaluated. 
OC performance, per subject 
 
DS 
(FEV1, symptom) 
DS 
(FEV1, MEFR) 
DS 
(MEFR, symptom) 
DS 
(FEV1, FEV1/FVC) 
|Tk| S FAR S FAR S FAR S FAR 
0.05 1.000 -- 1.000 -- 1.000 -- 1.000 -- 
0.1 1.000 5.56 1.000 -- 1.000 -- 1.000 -- 
0.15 0.957 4.48 0.980 5.75 0.950 7.80 0.898 5.85 
0.2 0.946 3.33 0.920 4.30 0.945 5.50 0.710 3.25 
0.25 0.924 3.04 0.780 3.05 0.785    3.55 0.603  2.25 
0.3 0.740 2.37 0.650 2.80 0.450 1.04 0.51 1.80 
0.4 0.559 1.87 0.511 1.30 0.310 0.40 0.22 1.10 
0.5 0.468 1.09 0.200 0.75 0.250 0.20 0.08 1.05 
pAUC 0.628 0.503 0.450 0.410 
Note: S: Sensitivity (%event); FAR: False Alarm Rate (#/subject-year); “-“ not evaluated. 
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Appendix D.  MATLAB Codes 
%function []=MA7baseF(DelThresh, PTmat) 
%define threshold: 0.85, 0.93 
decline=0.85;  
 
Xpt=X5198;  
Xpt=X5198; Xpt(511,:) = X5198(510,:); 
ev=[93 267]; 
  
%   x0=Xpt(:, 2)./Xpt(:, 3);   
eq= [Xpt(:,1)>=Xpt(:,2)]; 
Xpt(:,1)=Xpt(:,1)-eq.*Xpt(:,1)*0.09; 
x0=Xpt(:, 1);  
     
lev=length(ev); 
  
a=size(Xpt); 
n = a(1); 
  
xm7=filter(ones(1,7)/7,1,[(ones(1,6)*x0(1))'; x0]); 
xm30=filter(ones(1,30)/30,1,[(ones(1,29)*x0(1))'; x0]); 
    xm7=[xm7(7:n); xm7(n)*ones(1, 6)']; 
    xm30=[xm30(30:n); xm30(n)*ones(1, 29)']; 
     
figure(1);clf 
subplot(3, 1, 1); 
    signal=x0; 
    plot(signal); 
    miny=min(signal); 
    maxy=max(signal);   
     
    axis([0 n miny maxy]); 
    hold 
    title('Original Signal'); 
    
    for i=1:lev 
        plot(ev(i), [miny:(maxy-miny)/100:maxy], 'r-')   
        ev(i) 
    end            
    hold off;   
      
     
subplot(3, 1, 2);   
    hold on; 
     
%run DetectFFr.m to get s 
% s0=s(range); s0=s0(2:845); 
% plot(s0, 'g-')   
  
%detection loop 
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xm7max=zeros(1, n)'; 
    xm7max(1:7)=max(xm7(1:7)); 
    for i=8:n       
        xm7max(i)=max(xm7(i-6:i)); 
    end     
    xm7=xm7(1:n); 
    xm7CMP=[(1:n)' x0 xm7max [x0< (xm7max*decline)]]; %short memory, 
compare to 7 days only 
     
    lineX0=xm7CMP(xm7CMP(:, 4)==1);  
        disp('lineX0');        
    nl=length(lineX0) 
    for i=1:nl 
        plot(lineX0(i)*ones(1, 2), [miny*1.05; maxy]', 'y-')   
    end    
     
%plot data on top of background 
    plot(xm7) %remove padding 
    axis([0 n miny maxy]);  
    hold on; 
    plot(xm30, 'g-') 
    hold on; 
  
%long term memory     
%     xm7=xm7(7:n); 
subplot(3, 1, 3);   
    hold on;     
xm7base=zeros(1, n)'; 
    xm7base(1:42)=max(xm7(7:14)); 
    xm7base(43:72)=max(xm7(35:42)) ; 
    xm7base(73:180)=max(xm7(65:72)); 
    xm7base(181:242)=min(xm7(170:180)); 
    xm7base(243:270)=max(xm7(235:242))  ; 
    xm7base(271:287)=min(xm7(260:270)); 
    xm7base(288:300)=max(xm7(281:287)); 
    xm7base(301:n)=max(xm7(295:300));  
     
    xm7CMP=[(1:n)' x0 xm7base [x0< (xm7base*decline)]]; %short memory, 
compare to 7 days only 
     
    lineX=xm7CMP(xm7CMP(:, 4)==1);    
                disp('lineX');  
    nl=length(lineX) 
    for i=1:nl 
        plot(lineX(i)*ones(1, 2), [miny*1.05; maxy]', 'y-')   
    end    
     
  
%plot data on top of background 
    plot(xm7) %remove padding 
    axis([0 n miny maxy]);  
    hold on; 
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    plot(xm30, 'g-') 
    hold on;     
     
disp('NEW TP FP')        
[length(lineX(lineX<93)) 
length(lineX(lineX> 93 & lineX<267))     
length(lineX(lineX>267))] 
        
     
% Created by Wayne X. Wang 
Symptom Data Processing 
if (PT=='3028') 
data=data3028Copy; 
xi=[2 4 9 10 12:15 17:25 27:36 38:49]'; %tract unfilled indices 
end 
 
 
data1=[data(:, 1) data(:, 10:15)]; 
% data=data30; 
% xi=[]'; 
Cgh= interp1(data1(:,1),data1(:, 2),xi);  
SAmt= interp1(data1(:,1),data1(:, 3),xi);  
SCl= interp1(data1(:,1),data1(:, 4),xi);  
Whz= interp1(data1(:,1),data1(:, 5),xi);  
ShBr= interp1(data1(:,1),data1(:, 6),xi);  
Wbg= interp1(data1(:,1),data1(:, 7),xi);  
  
datax=[data1(:, 1:7); [xi Cgh SAmt SCl Whz ShBr Wbg]]; 
dataxs= sortrows(datax,1); 
%mimic baseline in original paper, reset missing value as zero 
%Dyspnea 
     xShBr=dataxs(:,6); xShBr=xShBr.*[xShBr>0];% x=xb; clf; 
TITLE('Dyspnea and Events')  
%Wheeze     
     xWhz=dataxs(:,5); xWhz=xWhz.*[xWhz>0];% x=xw; clf;TITLE('Wheeze 
and Events')  
  
%Sputum (color, amount) 
    xSAmt=dataxs(:,3); xSAmt=xSAmt.*[xSAmt>0];  
    xSCl=dataxs(:,4); xSCl=xSCl.*[xSCl>0]; %x=xc/3+xa/3;% TITLE('Sputum 
(color, amount) and Events')  
  
%Dyspnea+Wheeze+Sputum (color, amount)/3 (weighted sum) 
%     x=xb+xw+xc/3+xa/3;clf;TITLE('Dyspnea+Wheeze+Sputum(weighted sum) 
and Events')  
  
%Cough    
    xCgh=dataxs(:,2); xCgh=xCgh.*[xCgh>0]; %clf; %x=xg;TITLE('Cough and 
Events')  
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%Relative terms: cough, sputum (amount and color) 
    x=(xCgh+xSAmt+xSCl);  
%Absolute terms (dyspnea+wheeze)     
    x2=xShBr+xWhz; clf; 
  
%freeze current week x data and compare to baseline 
%baseline 
lxz=length(x); 
  
wi=floor(length(x)/7); 
  
z(1)=0; 
if wi>0 
z(2)=mean(x(1:1*7));  % for week 2 data 
end 
if wi>1 
    z(3)=mean(x(1:2*7)); % for week 3 data 
end 
if wi>2 
z(4)=mean(x(1:3*7));% for week 4 data 
end 
if wi>3 
z(5)=mean(x(1:4*7));% for week 5 data 
end 
if wi>4 
z(6)=mean(x(1:5*7));% for week 6 data 
end 
if wi>5 
z(7)=mean(x(1:lxz));% for week 7 data     
end 
if wi>6 
z(7)=mean(x(1:6*7));% for week 7 data 
end 
if wi>7 
z(8)=mean(x(1:7*7));% for week 8 data 
end 
  
% wi=150; %wi>=9 
if wi>8 
for i=9:wi 
    z(i)=mean(x((i-9)*7+1:(i-1)*7)); 
end 
end 
  
%eg, week i=2 detection 
xdiff=x(1:7); 
  
for i=2:wi 
    xnow=x((i-1)*7+1:i*7); 
    xbase=[ones(7,1)*z(i)]; 
    xtmp=xnow-xbase; 
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xdiff=[xdiff; xtmp]; 
end 
res=(length(x)-7*wi); 
  
if wi>8 
    z(wi+1)=mean(x((wi-8)*7+1:wi*7)); 
    xnow=x(wi*7+1:length(x)); 
    xbase=[ones(res,1)*z(wi+1)]; 
    xtmp=xnow-xbase; 
end 
if wi==7 
%     z(wi+1)=mean(x((wi-5)*7+1:wi*7)); 
    xnow=x(wi*7+1:length(x)); 
    xbase=[ones(res,1)*z(wi+1)]; 
    xtmp=xnow-xbase; 
end; 
  
xdiff=[xdiff; xtmp]; 
  
% absolute term: x=xb+xw+xc/3+xa/3 
% relative term: xdiff of cough, sputum (amount and color) 
xx=x2+xdiff/2; % absolute + relative scores/2 (weighted) 
 
ssw3028= xx; % save the converted data 
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Wavelet-based Event Detection 
Signal Noise Ratio using a sliding window 
%MA estimate    
xz=X(lx:-1:1,1); 
    xmz7pad=filter(ones(1,7)/7,1, [(ones(1,7)*xz(1))'; xz]); %add 7 day 
padding 
    xmz7=xmz7pad(8: (lx+7)); %remove padding 
     
    snr0=zeros(1,lx);  
    snr=zeros(1,lx);  
    eti=zeros(1,lx); 
    ns=2; 
    for i=2:floor(lx/ns) 
        starti=ns*(i-1)+1-ns; 
        stopi=ns*i; 
        xi=X(1: stopi);           
        [V1tmp,CXDV1,LXDV1]   = wden(xi,'sqtwolog','s','one',3,'db3');  
            V1(stopi-10+1: stopi)=V1tmp(stopi-10+1:stopi);     
                       
        snr0(stopi-10+1: stopi)=norm(xmz7(stopi-10+1: 
stopi))./norm(xi(stopi-10+1: stopi) - xmz7(stopi-10+1: stopi));   
        snr(stopi-10+1: stopi)=norm(V1(stopi-10+1: 
stopi))./norm(xi(stopi-10+1: stopi) - V1(stopi-10+1: stopi));   
    end    
     
subplot(211), plot(1:lx, X); hold on; plot(1:lx, V1, 'r'); plot(1:lx, 
xmz7, 'm'); 
subplot(212), plot(1:lx, snr0); hold on; plot(1:lx, snr) 
plot(1:lx, snr./snr0) 
  
% Use segments to show statistical significance 
ns=20; %non overlapping; 
block=floor(lx/ns); 
snrb=zeros(1, block); 
snrb0=zeros(1, block); 
z=zeros(1, block); 
   for i=1:floor(lx/ns) 
        starti=ns*(i-1)+1; 
        stopi=ns*i;      
         
        snrb(i)=norm(V1(starti: stopi))/norm(X(starti: stopi) - 
V1(starti: stopi))   
         snrb0(i)=norm(xmz7(starti: stopi))/norm(X(starti: stopi) - 
xmz7(starti: stopi))  
 %Z(i)=(mean(snrb(i))-
mean(snrb0(i)))/sqrt(std(snrb0(i))*std(snrb0(i))+std(snrb(i))*std(snrb(
i)))          
   end   
   plot(snrb0, snrb, '+')    
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Multiscale analysis 
See modwt.m, modwtjm.m in Percival’s WMSTA  
function [Wtout, Vtout] = modwtjm(Vtin, ht, gt, j) 
% modwtjm -- Calculate jth level MODWT coefficients (MATLAB 
implementation). 
% 
%****f* wmtsa.dwt/modwtjm 
% 
% NAME 
%   modwtjm -- Calculate jth level MODWT coefficients (MATLAB 
implementation). 
% 
% SYNOPSIS 
%   [Wtout, Vtout] = modwtjm(Vtin, ht, gt, j) 
% 
% INPUTS 
%   * Vtin        -- Input series for j-1 level (i.e. MODWT scaling 
coefficients)  
%   * ht          -- MODWT wavelet filter coefficients. 
%   * gt          -- MODWT scaling filter coefficients. 
%   * j           -- level (index) of scale. 
% 
% OUTPUTS 
%   * Wtout       -- MODWT wavelet coefficients for jth scale. 
%   * Vtout       -- MODWT scaling coefficients for jth scale. 
% 
% SIDE EFFECTS 
% 
% DESCRIPTION 
%   modwtjm is an implementation in MATLAB code of the MODWT transform 
for the jth level. 
% 
%   the MODWT transform, modwtj, which linked in as a MEX function. 
N = length(Vtin); 
  L = length(ht); 
   
  Wtout = zeros(N, 1) * NaN; 
  Vtout = zeros(N, 1) * NaN; 
   
  for (t = 1:N) 
    k = t; 
    Wtout(t) = ht(1) * Vtin(k); 
    Vtout(t) = gt(1) * Vtin(k); 
     
    for (n = 2:L) 
      k = k - 2^(j-1); 
      if (k < 1) 
        k = k + N; 
      end 
147 
      Wtout(t) = Wtout(t) + ht(n) * Vtin(k); 
      Vtout(t) = Vtout(t) + gt(n) * Vtin(k); 
    end 
  end     
 
DWT.m, WDEN.m SWT.m see MATLAB7 
Compute wavelet regression and CUSUM 
%WDEN.m is a MATLAB7 function 
%  WDEN Automatic 1-D de-noising using wavelets. 
%     WDEN performs an automatic de-noising process of a 1-D 
%     signal using wavelets. 
%   
%     [XD,CXD,LXD] = WDEN(X,TPTR,SORH,SCAL,N,'wname') returns  
%     a de-noised version XD of input signal X obtained by  
%     thresholding the wavelet coefficients.  
%     'sqtwolog' for universal threshold sqrt(2*log(.)). 
%     SORH ('s' or 'h') is for soft or hard thresholding 
%     SCAL defines multiplicative threshold rescaling: 
%       'one' for no rescaling. 
%       'sln' for rescaling using a single estimation  
%         of level noise based on first level coefficients. 
%       'mln' for rescaling done using level dependent 
%         estimation of level noise. 
%     Wavelet decomposition is performed at level N and 'wname' 
%     is a string containing the name of desired orthogonal 
%     wavelet. 
 
%Getting wavelet estimates V1, V2 
        [V1,CXDV1,LXDV1] = wden(X,'sqtwolog','s','one',2,'db3'); %; 
        [V2,CXD5V2,LXD5V2] = wden(X,'sqtwolog','s','one',5,'db4');  
  
% Calculating trend difference 
V3=V1-V2; %trend difference 
V4=V3.*(V3<0); %subzero trend difference 
V5=V3.*(V3>=0); %above zero trend difference 
V6=V5(lx:-1:1); 
 
% Visualize with events 
if (PT=='5183') 
    ev=[26 95 215 277]; 
    lev=length(ev); 
     
    for i=1:lev 
        plot((ev(i))*ones(1,2), [minx; maxx], 'r-')   
    end           
end  
% Compute CUSUM (positive and negative) 
cum=zeros(lx,1); 
cumi=0; 
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for i=1:lx 
    if V4(i)==0 cumi=0; 
        else cumi=cumi+V4(i); 
    end         
    cum(i)=cumi;     
end 
plot(cum, 'm-'); 
  
  
cumn=zeros(lx,1); 
cumri=0; 
for i=1:lx 
    if V6(i)==0 cumri=0; 
        else cumri=cumri+V6(i); 
    end      
    cumnr(i)=cumri;     
end 
cumnn=cumnr(lx:-1:1); 
plot(cumnn, '-'); 
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Dempster-Shafer Combination  
 
The DS combination rule 
B=.9; A=0.1; 
[mSx mNx mUx]=bpafunction(DStestInputA, A,B); 
[mSy mNy mUy]=bpafunction(DStestInputB, A,B); 
 
function [mS mN mU]=bpafunction(cfv, A,B) 
mS=B/(1-A)*cfv-A*B/(1-A); 
mN=-B/(1-A)*cfv+B; 
  
mS=mS.*[mS>=0]; 
mN=mN.*[mN>=0]; 
mU=1-mS-mN; 
 
function [mSxy, mNxy, mUxy] =DSfusion(mSx, mNx, mUx, mSy, mNy, mUy) 
% [mSx mNx mUx] mSx: nx1 vector 
  
mSxy=(mSx.*mSy+mSy.*mUx+mSx.*mUy)./(1-mNx.*mSy-mSx.*mNy); 
mNxy=(mNx.*mNy+mNx.*mUy+mUx.*mNy)./(1-mNx.*mSy-mSx.*mNy); 
  
mUxy=(1-mSxy-mNxy); 
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A DS Case example with classification 
 
cfv1org=1./(1+exp(-2.49*(v1-0.402))); % cfv for FEV1(v1) 
cfvsorg=1./(1+exp(-2.48*(vs-0.403))); % cfv for symptom(vs) 
 
% bpa for FEV1 
B=0.9; A=0.1; 
[mSx mNx mUx]=bpafunction(cfv1org, A,B); 
[mSy mNy mUy]=bpafunction(cfvsorg, A,B); 
  
%event window 
    for i=1:lev 
        evstart=(ev(i)-7*3); 
        evend  =(ev(i)+7*1); 
        if evstart<=0 evstart=1; end 
        if evend > length(v) evend=length(v); end            
        ew(evstart: evend)=1; 
  
        plot((ev(i))*ones(1,2), [0; 1], 'r-', 'LineWidth',3)   
         
    end   
ew; 
plot(1:length(v1), -ew/8, 'k--')  
 
% DS2 fusion  
[mSxy, mNxy, mUxy]=DSfusion(mSx, mNx, mUx, mSy, mNy, mUy); 
EWmS=ew.*mSxy;  
mSxy1=(mSxy-min(mSxy))/(1-min(mSxy)); %normalized to (0-1) 
plot(1:length(v1), mSxy1, 'b', 'LineWidth',2) 
  
 
